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Mankind has been interested in our senses and how they function for a very long time. Already 
Aristotle in his work “De Anima” was thinking about our senses. Although he postulated that 
there are only five senses, namely sight, hearing, taste, smell and touch, which is not correct 
from today’s perspective, he nevertheless drew the conclusion that we have more than one 
sense so that we do not miss out on information. If we now confer his statements to today’s 
environment we could imagine the following situation. While having a nice dinner in the 
evening we see the person next to us, we hear music, we first smell and then taste the food. All 
the impressions sum up to a big picture in the end which can be impaired by just one sense 
missing. For instance, without the sense of hearing communication would be much harder, 
dangers for example those of traffic could not be detected that fast and we wouldn´t know the 
true pleasure of music.  
 
1.1 The mammalian ear 
 
1.1.1 Anatomy of the ear 
 
The ear is subdivided into three parts called outer ear, middle ear and inner ear. Only the outer 
ear is visible whereas the other two parts are located inside the temporal bone. The outer ear 
consists of the pinna, the external ear canal and the tympanic membrane and is responsible for 
funneling the sound. Additionally the outer ear helps to localize sound coming from front, back, 
top or bottom but has no influence on the localization of sound from left or right (Heffner and 
Heffner, 2008). For this binaural hearing the detection of small differences in time and intensity 




The middle ear is composed of the three smallest bones in the human body, malleus, incus and 
stapes, which can be summarized as ossicles They are responsible for impedance matching 
between two media: air, having low impedance, and a non-compressible fluid with higher 
impedance, thus ensuring the transmission from sound from the outer ear to the inner ear. The 
middle ear increases the sound pressure using the leverage of the three ossicles for focusing 
the energy from the tympanic membrane onto the much smaller oval window of the cochlea 
compare Fig. 1.1 A).  
The inner ear is separated into the semicircular canals which are of great importance for 
balance and the cochlea. Inside the cochlea the organ of Corti as the organ of hearing is 
localized. Both parts of the inner ear rely on hair cells for detection of information. 
 
Figure 1.1: Drawings of the anatomy of the inner ear. A) The ear is separated into outer ear, middle ear 
and inner ear, the latter contains the vestibular system and the cochlea. B) The organ of Corti, on the 
one hand inside the cochlea and on the other hand enrolled is shown. C) The localization of the organ of 
Corti with outer hair cells and inner hair cells is depicted. D) The organ of Corti with tectorial and basilar 




1.1.2 The Cochlea 
 
The cochlea (compare Fig. 1.1 B) is composed of three fluid filled canals, namely scala tympani, 
scala media and scala vestibuli. In the scala media the organ of Corti is localized. Scala tympani 
as well as scala vestibuli are filled with perilymph whereas scala media is filled with endolymph. 
These two fluids differ regarding their ion concentrations. Endolymph is a high potassium 
solution whereas perilymph has a high sodium concentration. This difference plays an 
important role in the transduction of sound from the organ of Corti to the brain. Scala tympani 
and scala vestibuli are separated from scala media by the basilar and the Reissner’s membrane, 
respectively. At the apex of the organ of Corti scala tympani and scala vestibuli are linked via 
the helicotrema. The human organ of Corti winds inside the cochlea about two and a half turns 
and is accompanied by the stria vascularis, a tissue rich in blood vessels which maintains the ion 
concentration of the endolymph (compare Fig. 1.1 C).  
The third ossicle of the middle ear, the stapes, has contact to the oval window and transports 
the mechanical impulse from the ossicles to the fluid filled inner ear. The vibration of the 
ossicles is thus transmitted to the perilymph of the scala vestibuli and results in a pressure 
wave, called a travelling wave. The position of the travelling wave´s maximum deflection within 
the cochlea depends on its frequency. Low frequency sounds lead to a maximum near the apex 
whereas high frequency sounds result in a maximum which is located near the base. This fact 
leads to tonotopic organization in the auditory pathway. The organ of Corti of mice has 1.75 
turns and the detectable sounds range from 1 to 100kHz whereas the organ of Corti of humans 
is longer and can detect sound from 10Hz to 20kHz (Fettiplace and Hackney, 2006).  
 
1.1.3 The organ of Corti 
 
Our hearing organ, the organ of Corti, is situated on top of the basilar membrane. It consists of 




cells, which can be found in three rows and the inner hair cells which only consist of one row. 
Both types are running the full length of the cochlea. Other cell types like pillar cells or Deiter’s 
cells mechanically support the hair cells or maintain their ion homeostasis.  
 
1.1.4 Cochlear hair cells 
 
The hair cells in general are required for signal amplification and for converting the mechanical 
sound stimulus to an electrical signal. Outer hair cells mainly increase the amplitude of the 
deflection of the basilar membrane, while inner hair cells together with their synapses and 
spiral ganglion neurons are responsible for sound coding. In humans about 12,000 outer hair 
cells and 3,500 inner hair cells can be found (Dallos, 1992). Both types of hair cells possess so 
called stereocilia, long extensions on the apical part. Stereocilia of the outer hair cells are in 
direct contact with the tectorial membrane, unlike those of the inner hair cells (compare Fig. 
1.1 D). Sound stimuli result in vertical vibration of the basilar membrane which lifts and lowers 
the organ of Corti. This in turn leads to a shearing force between the hair bundles of the outer 
hair cells and the tectorial membrane. Subsequently the fluid flow causes a deflection of the 
stereocilia of outer hair cells which in turn leads to opening of mechanoelectrical transduction 
channels in the tips of the stereocilia. In consequence, potassium can enter the cell and 
depolarize it.  
The lateral membrane of the outer hair cells is densely packed with prestin, a protein which has 
the ability to alter its conformation depending on the voltage (Oliver et al., 2001). Those 
conformational changes lead to contraction when the cell is depolarized and to elongation in 
hyperpolarized state (Kachar et al., 1986). This mechanism is required for the signal 
amplification in the cochlea (Liberman et al., 2002).  
The movement of the oscillating outer hair cells is transferred back to the basilar and tectorial 
membrane and also to the fluid-filled interspace surrounding the organ of Corti. Movement in 




transduction channels open and because the endolymph is potassium rich, K+ enters the cell 
through mechanoelectrical transduction channels causing a depolarization. The depolarization 
leads to the opening of voltage-gated Ca2+ channels at the inner hair cell active zone, located at 
the basal part of an inner hair cell.    
 
1.1.5 Exocytosis at inner hair cells 
 
The active zone contains the ribbon synapse, the type of synapse present in sensory hair cells. 
The opening of voltage-gated Ca2+channels leads to an influx of Ca2+ in the cell and to Ca2+ 
dependent exocytosis of glutamate filled vesicles at the ribbon synapse. Glutamate is detected 
by postsynaptic bouton-like terminals of SGN; the SGN depolarizes via activation of a-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors (Matsubara et al., 1996; 
Glowatzki and Fuchs, 2000). This leads to an action potential (AP) which is transmitted to the 
brain. Depending on the stimulus frequencies, action potentials in different hair cells are 
evoked and different auditory nerve fibers are stimulated. 
A striking feature of the inner hair cells is a specialized synapse, the so called ribbon synapse. 
Additionally, these synapses function with a different compilation of proteins than other types 
of synapses. Conventional synapses depend on N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) complexes; the main proteins are SNAP-25, syntaxin-1 or -2 and 
synaptobrevin. The Ca2+ sensor for fast exocytosis at the central synapse is synaptotagmin-1 or -
2 (Geppert et al., 1994). Already in 1999 it was shown that synaptotagmins 1–3, synaptophysin, 
and synapsin are absent from the inner hair cell synapse (Safieddine and Wenthold, 1999). 
Additionally, it was shown in 2011 that exocytosis at the hair cell ribbon synapse operates 
without SNARE proteins (Nouvian et al., 2011). It seems that this synapse has a different 
protein composition which includes otoferlin, a multi C2 domain protein which is needed for 





1.1.6  Deafness  
 
Hearing impairment is a frequent sensory deficit. As much as one in thousand children is 
affected by severe to profound hearing impairment at birth. The same number becomes deaf 
before they reach adulthood (Morton, 1991). Half of the occurring hearing loss, can be 
attributed to genetic reasons; which can be subdivided into two main categories. 10% of the 
patients are affected by syndromic hearing loss whereas 90% suffer from a non-syndromic form 
of hearing loss which does not coincide with other symptoms. For the latter different types, 
such as DFNA (autosomal dominant form), DFNB (autosomal recessive form) and DFNX (X-
chromosomal form) are known. 60 genes so far can be linked to DFNB 
(www.hereditaryhearingloss.org). One of those genes is otoferlin which causes DFNB9 
(Yasunaga et al., 1999). Mutations of otoferlin lead to an incorrectly transmitted auditory signal 
to the brain which in turn results in severe to profound hearing loss (Marlin et al., 2010). 
 
1.2 The ferlin protein family 
 
Ferlins are a family of large proteins (~200 – 240kDa) playing a role in vesicle fusion as well as 
membrane trafficking and exocytosis. In mammals six ferlin genes (Fer1L1 – L6) are encoded. 
The first three have the synonyms dysferlin, otoferlin and myoferlin, respectively. The six ferlins 
can be subdivided into two groups according to the absence or presence of a DysF domain, the 
function of which is not yet clear (Patel et al., 2008; Sula et al., 2014). Type-I ferlins, having a 
DysF domain, are dysferlin, myoferlin and Fer1L5.  Otoferlin, Fer1L4 and Fer1L6 are lacking the 
DysF domain and are accordingly classified as type-II ferlins. Ferlins have five to seven so called 
C2-domains which are characteristic for this protein family. Additionally, all ferlins include a 
unique domain called the Fer domain (compare Fig. 1.2) the function as well as structure of 
which are not yet unraveled (Lek et al., 2010). While mutations in otoferlin and myoferlin can 




limp-girdle muscular dystrophy type 2B respectively (Liu et al., 1998; Yasunaga et al., 1999), no 
disease-causing mutations were identified for dysferlin, Fer1L4, Fer1L5 or Fer1L6 yet. 
 
Figure 1.2: Domain topologies of mammalian ferlins: Ferlins of type I contain additionally FerA and FerB 
domains which are missing in ferlins of type II. Green: conserved features of all six ferlins, yellow: unique 
features. The DysF domain is separated into inner and outer part (adapted from Lek et al., 2010)  
 
Scientists took an insight in the tissue-specific expression, sub-cellular localization and 
endocytic trafficking of human ferlins (Redpath et al., 2015). They overexpressed all ferlins 
except Fer1L4 in HEK293, Cos-7 cells and C2C12 myoblasts for localization studies. It turned out 
that dysferlin, myoferlin and Fer1L6 are plasma membrane ferlins, contrasting otoferlin, which 
predominantly localizes in intracellular compartments. The localization of otoferlin close to the 
membrane seems to be very important for hearing. It was shown in deaf Otofpga/pga mice, which 
have a point mutation in the C2F domain, that the otoferlin membrane staining is greatly 
reduced (Pangrsic et al., 2010) (see also section 1.6).  
In HEK cells, dysferlin localizes to the plasma membrane and to endosomal vesicles (Evesson et 
al., 2010), whereas myoferlin only localizes to the plasma membrane (Bernatchez et al., 2009), 
otoferlin is predominantly intracellular (Redpath et al., 2015) and only at a very low level on the 
plasma membrane (compare Fig. 1.3). Getting even more into detail it was shown that 
myoferlin and dysferlin colocalize with markers for the secretory pathway and endosomes. 




 Mutations or absence of certain ferlins have severe consequences. The ferlin in Drosophila, 
called misfire, plays a role in fertilization and embryonic development. Males with mutant 
misfire show defects in sperm plasma membrane breakdown post fertilization (Ohsako et al., 
2003) whereas it was observed for females that some show abnormal egg markings. Those 
embryos behave abnormal in mitosis and development (Smith and Wakimoto, 2007). Fer-1 
mutants in C. elegans are infertile (Achanzar and Ward, 1997).  
 
 
Figure 1.3: Surface labelling of different human ferlins. Using C-terminal α-Myc Tag, which is luminal for 
intracellular and extracellular for ferlins in the plasma membrane, HEK293 cells were labeled. Dysferlin 
and myoferlin are abundantly expressed at the surface, neuronal form of otoferlin is not expressed at 
the surface at all whereas otoferlinub is expressed in low amounts. Scale bars: 10µm (adapted from 




Otoferlin, a ~220kDa protein and a member of the ferlin protein family consists of six C2-
domains (compare Fig. 1.4), C2A to C2F. A seventh C2 domain between C2D and C2E, called C2de 
is predicted but the similarity between this domain and other C2-domains is very low compared 





Figure 1.4: Protein domain structure of otoferlin showing all C2 domains, the coiled coil domain (CC), a 
ferlin-specific motif (FerB) domain in the middle of the protein and the transmembrane domain (TM) at 
the C-terminus. Mentioned on top are pathogenic missense mutations and in frame deletions, on the 
bottom sequence variants. Mutations shown in purple have been associated with temperature sensitive 
hearing loss. (Taken from Pangršič et al., 2012) 
 
The investigation of a generated otoferlin knockout mouse resulted in first ideas of the function 
of otoferlin (Roux et al., 2006). Although the number of ribbon-associated as well as docked 
vesicles is normal in these mutants, a great reduction in Ca2+ dependent exocytosis could be 
observed. From this it was concluded that otoferlin is fundamental for a late step of exocytosis 
(Roux et al., 2006), compare also Fig. 1.5). Inner hair cells of otoferlin knock out mice show 
spontaneous transmitter release as well as no detectable Ca2+ triggered exocytosis (Roux et al., 
2006; Pangrsic et al., 2010). Apart from the inner hair cells, otoferlin can also be found in 
immature outer hair cells as well as in type I hair cells of the vestibular system, where it is 
important for synaptic exocytosis (Beurg et al., 2008; Dulon et al., 2009). Immunogold electron 
microscopy experiments from Roux et al. revealed, that otoferlin is localized to synaptic vesicles 
and the plasma membrane (Roux et al., 2006; Pangrsic et al., 2010) which would be similar to 
the localization of synaptotagmin. So far otoferlin is believed to function as a synaptotagmin-
like Ca2+ sensor for fusion in inner hair cells (Roux et al., 2006) although this has not yet been 
demonstrated. Additionally, the investigation of an otoferlin mutant mouse line called 
“pachanga” raised the idea that otoferlin could play a role in vesicle replenishment and priming 
(Pangrsic et al., 2010). So far only of the C2A domain the crystal structure was solved (Helfmann 




1.4 Interaction partners of otoferlin 
 
Studies of otoferlin also include the identification of possible interaction partners of otoferlin. 
So far a few proteins are identified which seem to interact with otoferlin. It was shown that 
otoferlin directly interacts with syntaxin 1A, SNAP-25 and the L-type voltage gated Ca2+channel 
Cav1.3 (Ramakrishnan et al., 2009). However, later studies revealed that SNARE proteins are 
absent in inner hair cells (Nouvian et al., 2011). Two other stated interaction partners are 
myosin6 (Roux et al., 2009) and Rab8b GTPase (Heidrych et al., 2009, 2008). Another proposed 
interaction partner of otoferlin is adapter protein complex 2 (AP-2) (Duncker et al., 2013; Jung 
et al., 2015). AP-2 is essential for coated-vesicle formation (Keyel et al., 2008; Rappoport, 2008) 
and it was stated that otoferlin and AP-2 interact in mature inner hair cells (Jung et al., 2015). 
Otoferlin is present in low amounts in the brain as well. It was shown that it interacts in the 
brain with Ergic2 (Endoplasmic reticulum-Golgi intermediate compartment protein 2), a protein 
with still unknown function (Zak et al., 2012).  
However, none of these publications investigated an interaction in the inner hair cell itself but 
used different assays like surface plasmon resonance, pull-down and yeast two-hybrid assays. 
An examination whether this interactions take place in the inner hair cells as well would be 
meaningful. 
Two promising candidates for an interaction with otoferlin were dynamin and OPA1 (optic 
atrophy protein, a dynamin like GTPase). Both were, amongst other proteins, identified in pull-
down assays using mouse brain (performed by Sandra Meese (Molecular Structural Biology, 
Ralf Ficner) and Sunit Mandad (Bioanalytical Mass Spectrometry Group)). OPA1 is a dynamin-
like protein, which can be related to auditory neuropathy as well (Santarelli et al., 2015). For 
dynamin the localization in inner hair cells was shown already using immunofluorescence 
stainings (Neef et al., 2014). Dynamin-1 together with clathrin seems to play a role in 






1.5 Mutations in otoferlin 
 
Research is directed at the different mutations that can occur in otoferlin and in identifying new 
ones. Silent mutations on the level of nucleotides happen quite often but either do not change 
the amino acid sequence or do change it to a similar amino acid, where the function of the 
protein is preserved. Some mutations lead to a premature stop codon which results in a shorter 
form of the protein, those mutations are then called “nonsense” mutation. If the stop codon is 
located close to the C-terminus the protein could still be at least partially functional. The earlier 
such a mutation occurs, the more likely it is that the protein is not functional. In another 
mutation form, parts of the nucleotide or amino acid sequence are deleted. The smaller the 
deleted protein sequence the more likely it is that the protein remains functional to some 
extent whereas a deletion of a single nucleotide causes a frameshift which changes the whole 
amino acid sequence. The most frequent is the so called “Spanish mutation” which, after the 
transition from cytosine to thymine, results in a premature stop codon at position 829 (Q829X) 
(Migliosi et al., 2002).  
While most mutations in otoferlin lead to profound prelingual deafness, some mutations are 
known to cause different phenotypes. An interesting form of deafness is a transient form of 
hearing-loss, occurring when the patients’ core body temperature rises by as little as 1°C (Starr 
et al., 1998), for example because they become febrile or do sports. When the body 
temperature decreases again, the hearing status of affected patients returns to the previous 
level with a time lag of three to four days (Marlin et al., 2010). So far six of those temperature 
sensitive mutations have been described, all induced by an in frame mutation and a 
substitution of an amino acid or an amino acid deletion causing an in frame deletion. The 
described temperature-sensitive mutations are I515T (Varga et al., 2006b), G541S (Matsunaga 
et al., 2012), G614E (Romanos et al., 2009), R1080P (Romanos et al., 2009) R1607W (Wang et 
al., 2010) and E1804del (Marlin et al., 2010), and with compound heterozygosity for G614E and 




at normal body temperature but severe to profound hearing impairment at a temperature of 
38°C (Marlin et al., 2010). I515T and G541S mutation are located in the C2C domain, R1607W in 
the C2E domain and E1894del in the C2F domain. Since those mutations affect different domains 
of the protein, it will be interesting to find out whether they share the same general mechanism 
like fast degradation or heat instability.  
 
1.6 The “pachanga” mutation in the C2F domain of otoferlin 
 
The C2F domain of otoferlin already was the subject of intensive studies. The interest was raised 
because a mutation called “pachanga” (pga) was found in this domain. Mice having this 
mutation, Otofpga/pga , were profoundly deaf (Schwander et al., 2007; Pangrsic et al., 2010). In 
comparison with normal hearing wild type mice and Otof-/- mice, the latter also being 
profoundly deaf, differences could be observed (compare Fig. 1.5). In immunofluorescence 
stainings the otoferlin level in Otofpga/pga mice shows a strong reduction compared to the wild 
type, whereas staining is completely missing in Otof-/- mice (compare Fig. 1.5, B). Apart from an 
overall reduction of otoferlin staining in the inner hair cells of Otofpga/pga mice it is visible, that 
the membrane staining is strongly reduced. In Otof-/- mice exocytosis is nearly absent. In 
contrast in Otofpga/pga mice at least fusion of the readily-releasable pool seems to be intact, but 
sustained exocytosis is strongly reduced (compare Fig. 1.5 A). Comparing the results of Ca2+ 
uncaging of mutant to wild type mice, wild type mice show the release of a large pool of 
vesicles within milliseconds (indicated by black line, compare Fig. 1.5 C).  Although the time 
constant of Otofpga/pga mice is comparable to the one seen in Otof+/+ mice, the fast component 





Figure 1.5: Exocytosis and expression of otoferlin in Otof+/+, Otofpga/pga, Otof-/- mice. A) Behavior of 
sustained exocytosis (dashed line) and readily-releasable pool (RRP, grey line) of wild type mice (black) 
and both mutants (pga in green, knock out in purple) after depolarization. B) Immunofluorescence 
staining with α-otoferlin (green) and α-VGlut3 (vesicular glutamate receptor 3, purple) to show 
expression in inner hair cells, wild type IHCs on top, pga IHCs in the middle, otoferlin knockout IHCs on 
the bottom. C) Exocytosis upon Ca2+ uncaging (adapted from Pangršič et al., 2012) 
 
1.7 The Gene Gun method for cell transfection 
 
Different ways for transfecting cells like lipofection (for example using Lipofectamine®, 
Thermofisher) exist, but none of them proved successful so far for transfecting cochlear inner 
hair cells (Kirsten Reuter-Jessen and Ellen Reisinger, personal communication).  
So far it has been shown that inner hair cells can be genetically manipulated by virus 
transfection and it was efficient for adeno-associated virus (AAV) serotype 1/2, adenovirus (Ad) 
serotype 5 and lentivirus (Luebke et al., 2001; Bedrosian et al., 2006). Otocyst as well as 
postnatal injection of mice ranging between p3 to around p14 has been established in our 
laboratory (Reisinger et al., 2011; Jung et al., 2015), both methods depend on the usage of AAV 




restricted capacity of roughly 2.5kb – 3kb which is smaller than the size of otoferlin (~6kb). 
Moreover, production of AAVs is laborious and usually takes several weeks of time.   
A relatively new transfection method is the Gene Gun or biolistic (neologism combining bio and 
ballistic) transfection, invented by Nelson Allen, John Sanford and Ed Wolf (Klein et al., 1987; 
Sanford et al., 1987). Originally designed to infect plant cells, it uses helium pressure and cDNA 
coated gold or tungsten particles for transfection. Particles of varying size are coated with the 
desired cDNA and those gold particles are shot into the tissue of interest. Transfection of 
Drosophila embryos (Baldarelli and Lengyel, 1990), HEK293 and HeLa cells (O’Brien et al., 2001), 
larvae of Bombyx mori (Thomas et al., 2001) and bullfrog saccule (Zhao et al., 2012) was proven 
successful. Thomas et al. self-built a shooting module since the results obtained with the 
BioRad module were not satisfying. They used coated gold particles and a helium pressure of 
either 1100psi or 1800psi. However, Baldarelli and Lengyel used tungsten instead of gold 
particles, the transfection pressure is not noted. Same as Thomas et al., O’Brien et al. modified 
the BioRad Gene Gun for their purposes. They troubled having either a too high pressure 
(175psi) thus destroying the cells or lower pressure (50 – 100psi) with low efficiency before 
modification. After modification the pressure could be decreased and transfections lead to 
transfected cells. Furthermore, Zhao and colleagues used a self-built setup using common 
laboratory equipment to reduce helium pressure. They were able to increase the pressure up to 
200psi and still observe healthy looking cells. Additionally in all those differences in pressure 
and further modifications also the preparation of Gene Gun bullets differed regarding carrier 
(gold or tungsten), particle size (1µm – 1.6µm in diameter), amount of DNA (4µg – 50µg) and 
preparation protocol. It seems that, depending on the tissue that has to be transfected, all the 
different parameters have to be modified to get satisfying results.  
Advantage of Gene Gun transfection over virus transduction are that even large constructs, 
larger than possible in virus transduction, as well as two constructs in parallel can be used. 





1.8 Aims of this study 
 
The aim of my PhD project could be separated into three major parts. 
First, I was aiming to transfect inner hair cells with a variety of mutated otoferlin constructs. To 
reach this aim I combined cloning approaches to generate the otoferlin mutants and 
established biolistic transfection of inner hair cells using Gene Gun. 
Secondly, I was interested in the underlying mechanism of temperature sensitive hearing loss. 
For that purpose I subcloned temperature sensitive otoferlin mutations and compared the 
protein expression at normal body temperature of 37°C as well as at elevated temperature of 
38.5°C. Therefore different approaches such as overexpression of proteins in HEK cells, 
quantitative Real-Time PCR and immunofluorescence stainings had to be performed to 
elucidate the effect of temperature on otoferlin. 
Third, I was working on the identification of interaction partners of otoferlin by applying 
proximity ligation assays, a method that serves to visualize protein interaction in inner hair 
cells. Although interaction partners of otoferlin are identified using different methods, none of 
those were reviewed if the proteins interact in inner hair cells as well. Since this method was so 








Lab Equipment  
Adjustable pipettes Brand 
Agarose gel electrophoresis chambers  BioRad 
Cell incubator Midi 40 Thermo Scientific 
Cell incubator HERAcell 150i Thermo Scientific 
Cell incubator HERA cell Thermo Scientific 
Centrifuge Heraeus Fresco 17 Thermo 
Centrifuge Heraeus Pico 17 Thermo 
Centrifuge 5424R Eppendorf 
Centrifuge Avanti® J-30I Beckmann Coulter 
Electrophoresis Power Supply MP 300V (for agarose gel electrophoresis) major science 
Electrophoresis Power Supply EPS 301 (for Western Blots)  GE healthcare 
Gel documentation UV system INTAS 
Helios® Gene Gun BioRad 
Gene Gun Tubing Prep Station BioRad 
Gene Gun Tubing Cutter BioRad 
Microscope Axiovert 40 CFL with HBO 50 lamp Zeiss 
Microscope SP5 Leica 
NanoVue plus GE Healthcare 
Real-Time PCR 7500 Sequence detection system Applied Biosystems 
Sonification water bath Transonic 820/H Elma 
Sonification Sonopuls Brandelin 
Sonification Sonifier 250 Branson 
Sterile work bench HERA safe Thermo Scientific 




Thermocycler My Cycler BioRad 
Thermocycler T100™ Thermal Cycler BioRad 
Thermomixer comfort Eppendorf 
Thermomixer Compact Eppendorf 
Western Blot chemiluminescence detection Chemo Cam INTAS 
Western Blot/SDS gel electrophoresis Mini PROTEAN® 3 cell BioRad 
 
Kits  
DNA Clean Up Zymoclean™ Gel DNA Recovery Kit Zymo Research 
Gel Extraction Zymoclean™ Gel DNA Recovery Kit Zymo Research 
NucleoBond® PC 100 Machery-Nagel 
Plasmid extraction peqGOLD Plasmid Miniprep Kit I peqlab 
Size Standards  
Gene Ruler 100bp Plus                                                                                        Thermo Scientific 
Gene Ruler 1kb Plus Thermo Scientific 
Page Ruler™ Plus prestained Thermo Scientific 
Consumables  
Amersham™ Hybond ECL for Western Blot, nitrocellulose membrane GE Healthcare 
Cell Scaper Corning 
Cell Strainer Corning 
Falcon tubes Cellstar® Tubes greiner bio-one 
Lipofectamine® Thermofisher 
Minisart syringe filters Sartorius 
Petri dishes Cellstar® greiner bio-one 
Polypropylene Round-Bottom Tubes for plasmid isolation Corning 
Syringes BD plastipak™ 
Cell culturing  






DPBS (1x) Gibco 
HBSS (1x) Gibco 
HEPES buffer solution 1M Gibco 
HI NBCS Gibco 
Lipofectamine® 2000 Invitrogen 
OptiMEM Gibco 
Penicillin/Streptomycin 5,000units each Gibco 
Trypsin 0.25% EDTA (1x) Gibco 




Used chemicals were provided from Serva, Roth, Sigma or Invitrogen. Unless a district company 




For mouse experiments different mouse strains were used; wild type mice C57/Nbl6, Otof-/- 
OtofI515T/I515T and His6-HA-SUMO1 mice. Animal handling and experiments complied with 
national animal care guidelines, and were approved by the University of Göttingen Board for 
animal welfare and the animal welfare office of the state of Lower Saxony. 





2.3 Solutions for molecular biology 
 
11.1x PCR Buffer  
45mM Tris-HCL pH 8.8 
11mM ammonium sulphate 
4.5mM MgCl2 
6.7mM 2-mercaptoethanol 
4.4µM  EDTA pH 8.0 
1mM  of each dNTP 
113µg/ml BSA 
 
50x TAE Buffer 
0.4M Tris 
0.4M pure acetic acid 
10mM EDTA pH 8.0 
ad 1l H2O 
 
DNA Loading Dye 
50% Glycerol 
1mM EDTA pH 8.0 









Following vectors were used for cloning. All vectors already contained mOtoferlin as an insert 
which was not inserted by myself. The vector pBlueScript was used without any insert as well.  




2.5 Media and solutions for culturing 
 
Medium for culturing HEK cells 
89% DMEM media 
1% Penicillin/Streptomycin (final concentration 10µg/ml) 
10% NBCS 
 
Culturing organs of Corti 
Medium 




For allowing the attachment of biolistic transfected organs of Corti to the surface of a cover slip 




0.1M NaHCO3 (pH 8.0) buffer. The mixture was incubated until bubbles began to form. 14µl 
were pipetted on a coverslip and let dry. 
 
2.6 Solutions for immunohistochemistry 
 






PB (Phosphate Buffer) 
240mM Na2HPO4H2O 
 
GSDB/DSDB (goat serum dilution buffer/donkey serum dilution buffer) 
16% normal goat serum/normal donkey serum 
450mM NaCl 
0,3% Triton X-100 




20mM phosphate buffer 




Mowiol Mounting Medium 
2.4g Mowiol 4-88 were dissolved into 6g glycerol and 12ml H2Obidest were added. The solution 
was stirred for several hours at room temperature. Subsequently 0.2M Tris pH8.5 was added 
and the solution was heated for 1-2h at 50°C. After Mowiol was dissolved the solution was 
centrifuged (500g, 15min) and 2.5% DABCO was added. Mounting medium was stored at -20°C 
for longer storage, for short time storage it was kept at 4°C. 
 
2.7 Solutions for SDS polyacrylamide gel electrophoresis and 
Western Blot 
 
Composition of SDS polyacrylamide gels 
For 5ml running gel and 1ml stacking gel the following mixtures were used: 
Running gel 6%  
H2O 2.6ml 
30% Acrylamid (Rotiphorese® Gel 30 (37,5:1)) 1ml 
1.5M Tris (pH 8.8) 1.3ml 
10% SDS 50µl 
10% ammonium persulfate 50µl 
TEMED 4µl 
Stacking gel 5%  
H2O 680µl 
30% Acrylamid (Rotiphorese® Gel 30 (37,5:1)) 170µl 
1.5M Tris (pH 6.8) 130µl 
10% SDS 10µl 





2x Laemmli sample buffer 
50mM Tris pH 6.8 
2% SDS 
0.1% Bromophenolblue 
10% 87% glycerin 
ad 90ml H2Odest 
 











Ponceau S staining solution 
0.2% Ponceau S 








5% skimmed milk powder 
diluted in PBS 
 






Coomassie staining solution 
2.5g Brilliant Blue 
475ml EtOH 
100ml acetic acid 
425ml H2O 
 






3.1 Molecular biology 
 
3.1.1 Overview of cloning of mutated otoferlin constructs  
 
Since the importance and the role of a single C2 domain of otoferlin is not yet clear I generated 
otoferlin deletion constructs with a single missing C2 domain using site directed mutagenesis by 
overlap PCR (Ho et al., 1989). With that constructs it should be possible to investigate correct 
folding by transfecting and staining transfected HEK cells with each construct. Additionally, the 
distribution inside an inner hair cell using biolistic transfection and subsequent 
immunofluorescence staining can be observed.  With the help of site directed mutagenesis and 
overstretching primers it is possible to amplify a DNA section without a certain sequence and 
thus receive a shorter construct. An overview of the general workflow for generating the 
deletion constructs is shown in Fig. 3.1, deviations are mentioned in the sections explaining the 
cloning of a certain construct. To visualize the obtained product a vector map is depicted. The 
sequences of C2 domains were chosen according to the sequences predicted by Jiménez and 
Bashir, 2007 with exception of the C2A domain the sequence of which was determined using 
Helfmann et al., 2011.  
Cloning strategy and primer design were performed with the help of Gentle. Sequence was 
checked for correctness using Gentle and NCBI tool blast.  To delete a C2 domain it was usually 
started with two so called adapter PCRs. For those, suitable primers were used. Each pair 
consisted of one overstretching primer together with a primer that bound upstream or 
downstream of a chosen enzyme cutting site, matching with the orientation of the 
overstretching primer of course. The sequences of the overstretching primers were 




1989). The two cleaned products obtained in the previous adapter PCRs were mixed together 
and supplemented with common PCR ingredients. The used PCR programs are mentioned in 
the respective section. The product from the overlap PCR was cleaned and blunt subcloned into 
pBlueScript vector. The vector was transformed into XL1Blue cells. Colony PCRs were 
performed on the next day using the non-overstretching primers from the respective previous 
adapter PCRs. The whole PCR mix was loaded on an agarose gel to check for insert containing 
colonies. With those a plasmid preparation was performed. Three preparations were send for 
sequencing. In case of correct sequence insert-containing pBlueScript vector was digested using 
the enzymes previously chosen. The final vector pEGFPN1mOtof was digested using the same 
enzymes. Using a common ligation mixture, insert (obtained in overlap PCR) and vector 
(pEGFPN1mOtof) were ligated together. The product was transformed in XL1Blue cells and 






Figure 3.1: Overview of the used cloning strategy for obtaining mutated otoferlin constructs 
 
Mixtures, programs and procedures which were used without change for the generation of all 
C2 domain deletion constructs are mentioned below. All used enzymes and buffers were 
obtained from Thermo Scientific. 
Constructs with otoferlin point mutations were cloned into pcDNA3mOtof vector. For the 





Figure 3.2: Depicted are the four used vectors, with the main enzyme restriction sites, for generation of 
used constructs in this work 
 
Mixture of adapter PCR 
0.5µl Pfu 
0.3µl DNA Template 
0.5µl  Primer each 







Mixture of overlap PCR 
0.5µl Pfu 
9µl cleaned PCR product from PCR I 
9µl cleaned PCR product from PCR II 
0.5µl  Primer each 




All used primers and their sequence for adapter PCRs as well as overlap PCRs are mentioned in 
tables A1 and A2. For performing an overlap PCR the mixture without primers was incubated 
for three cycles to allow the overlapping sites to already align. 
 
Subcloning into pBlueScript and ethanol precipitation 
PBlueScript vector was linearized using EcoRV. The following mixture without Fast AP was 
incubated for 45min at 37°C, then 1µl Fast AP was added and incubated for another 15min at 
same temperature. 
2-3µg pBlueScript vector 
1µl EcoRV 
2µl  red buffer 
1µl  Fast AP 
20µl  
 





9µl cleaned PCR product 
1.5µl 10x T4 polynucleotid kinase buffer 
1µl 10mM ATP 




Both insert and vector where loaded on an 1% or 2% agarose gel, depending on the size of the 
insert, the correct size was confirmed. The insert was purified using the gel extraction kit. The 
DNA was then resuspended in 10µl H2Odest.  
For the ligation the following chemicals were mixed and incubated either for 2h at room 
temperature or overnight at 16°C. 
1µl linearized pBlueScript vector 
2µl 10x ligation buffer 
9µl cleaned PCR product 




After ligation the mixture was ethanol precipitated over night at -20°C using the following 
mixture. Before adding ethanol the solution was mixed by pipetting up and down a few times. 
20µl ligation mixture 
1µl Glycogen 
2.1µl 3M sodium acetate 






On the next day the precipitation was centrifuged (1h, 13300rpm, 4°C) and the supernatant was 
removed. The pellet was washed once in 70% EtOH (15min, 13300rpm, 4°C). After removing the 
supernatant the pellet was air dried and resuspended in 10µl H2Odest.   
XL1Blue cells were electroporated with the whole mix and incubated over night at 37°C. 
 
Identification of insert containing pBlueScript clones using colony PCR 
The colonies on the agar plate were checked whether they contain an insert or not. For that 
one colony was picked using a pipette tip and shortly incubated in 10µl H2Odest. The pipette tip 
was transferred to an Eppendorf tube containing 1ml of LB media supplemented with 
Carbenicillin (Roth, 50µg/ml). The water containing the template was then mixed with the 
required chemicals, the primers where the same as used in PCR for amplifying the insert. 
Mixture of the PCR and program were as followed: 
2µl 11x buffer 
0.2µl primer each 
1µl Dream Taq polymerase 
6.6µl H2Odest 









Variables in the PCR program, primer annealing and extension time, are marked by an x. The 
same temperature and time as in overlap PCRs was used, the extension time was adjusted to 
the length of the expected insert (30sec/1kbp). The whole PCR mixture was transferred to an 
agarose gel. Insert containing colonies were incubated overnight in 5ml LB medium 







Final cloning into pEGFPN1 
In case the sequence was correct pBlueScript vector with insert generated in the previous PCRs 
and pEGFPN1mOtof vector were digested using the chosen enzymes as mentioned below. 
Insert 
3-6µl buffer 
1µl enzyme each 










The digested vector and the produced insert were then ligated together. 
1µl ligase buffer 
0.6µl backbone pEGFPN1mOtof 
0.75µl Ligase 
7.65µl insert (digested insert from pBlueScript) 
10µl  
 
3.1.2 Cloning of pEGFPN1mOtof del C2A 
 
In contrast to the generation of the remaining deletion constructs cloning of pEGFPN1mOtof 
del C2A required only one adapter PCR instead of two and thus no overlap PCR. It was possible 
to choose the forward overlapping primer in a way that the enzyme cutting site of EcoRI was 
already located on the primer. The reverse primer was generated binding downstream of EcoRV 
restriction site. The PCR was performed using the previously mentioned mixture (see section 




(CTTCGAATTCGCCACCATGGCCGCCACAGATGGCACTGTGGGC) and pEGFPN1mOtof del C2A, rev 
(ATCTTGTCTTTGGGGCTCCT) were used. 
95°C 3min 






The PCR product was loaded on a 2% agarose gel, the correct band (size 292bp) was cut out and 
the DNA was then purified using the Gel extraction kit. Following steps were performed as 
already mentioned in section 3.1.1. For digestion with EcoRI and EcoRV 2x Tango Buffer was 
used.  
In Fig. 3.3 pEGFPN1mOtof vector before and after removal of the C2A domain are shown.  
 
Figure 3.3: Depicted are vector maps of pEGFPN1mOtof vector before removing the C2A domain (left) 





location of the used primers is indicated in purple. The overstretching primer is shown as two parts, 
indicating the part binding upstream and downstream of the C2A domain. Eco32 = EcoRV 
 
3.1.3 Cloning of pEGFPN1mOtof del C2B 
 
To obtain a deletion construct of mouse otoferlin with a missing C2B domain in the pEGFPN1 
vector the desired sequence was removed using two pairs of designed primers in two adapter 
PCRs followed by one overlap PCR, using both obtained products from the previous PCRs as 
templates (compare Fig. 3.1). The obtained product was amplified and subcloned into 
pBlueScript using blunt end ligation. The insert was sequenced and, in case of a correct 
sequence, digested with the enzymes EcoRV and SalI and finally cloned into pEGFPN1 mOtof. 
Two adapter PCRs in a mixture as stated previously were performed as followed. For PCR1 and 
PCR2 primer pairs pEGFPN1mOtof del C2B PCR1, for (AAGGACAGCCAGGAGACAGA) and 
pEGFPN1mOtof del C2B PCR2, rev (TGCCCACCACCTGGTAATCCATGGGCCTTC) as well as for PCR2 
pEGFPN1mOtof del C2B PCR2, for (ATTACCAGGTGGTGGGCAAGGGAGACAAC) and 
pEGFPN1mOtof del C2B PCR2, rev (GCTGCTCTTCTGCACTGATG) were used, respectively.  
Adapter PCR1  
95°C 3min 





Adapter PCR2  
95°C 3min 






The expected sizes of PCR1 and PCR2 were 391bp and 293bp respectively. The PCR products 
were loaded on a 2% agarose gel, the correct band was cut out and the DNA was then purified 





Primers pEGFPN1mOtof del C2B PCR1 for and pEGFPN1mOtof del C2B PCR2 rev were used. The 
PCR program is mentioned below. Afterwards the PCR was again loaded on a 2% agarose gel 
and the correct band (size 666bp) was cut out and purified using the gel extraction kit. 
95°C 5min 









Ligation procedure of overlap product and pBlueScript vector was conducted as previously 
stated. Both insert and vector were loaded on a 1% agarose gel where the correct size was 
confirmed and cleaned using the gel extraction kit. After ligation the whole mix was 
electroporated into XL1Blue cells and incubated over night at 37°C. Colony PCRs were done the 
next day. 
In case the sequence was correct, pBlueScript vector with del C2B insert and pEGFPN1mOtof 
vector were digested using EcoRV and SalI using 2x Tango Buffer as mentioned below. 
Insert 
6µl Tango buffer 
1µl enzyme each 





6µl Tango Buffer 









The digested vector and the produced insert were then ligated together. 
In Fig. 3.4 pEGFPN1mOtof vector before and after removal of the C2B domain are shown.  
 
Figure 3.4: Depicted are vector maps of pEGFPN1mOtof vector before removing the C2B domain (left) 
and afterwards (right). The used restriction enzymes as well as their location are shown in red; the 
location of the used primers is indicated in purple. The overstretching primer is shown as two parts, 
indicating the part binding upstream and downstream of the C2B domain.   
 
3.1.4 Cloning of pEGFPN1mOtof del C2C 
 
To obtain a deletion construct of mouse otoferlin with a missing C2C domain in the pEGFPN1 
vector, the desired sequence was removed using two pairs of primers in two adapter PCRs, 
followed by one overlap PCR, using the both obtained products from the previous PCRs as 
templates (compare Fig. 3.1). The obtained product was amplified and subcloned into 
pBlueScript using blunt end ligation. The insert was sequenced and, in case of a correct 
sequence, digested with the enzymes SanDI and EcoRV and finally cloned into pEGFPN1 mOtof. 
Two adapter PCRs in a mixture as stated previously were performed as followed. For PCR1 and 
PCR2 primer pairs pEGFPN1mOtof del C2C PCR1, for (AAGGACAGCCAGGAGACAGA) and 




pEGFPN1mOtof del C2C PCR2, for (GTGGGCACGGACGCGCAACTACACACTGCTG) and 
pEGFPN1mOtof del C2C PCR2, rev (ACAGAGGCGTGTCAGGATCT) were used, respectively.  
Adapter PCR1  
95°C 3min 






Adapter PCR2  
95°C 3min 





The expected sizes of PCR1 and PCR2 were 880bp and 3187bp respectively. The PCR products 
were loaded on a 1% agarose gel, the correct band was cut out and the DNA was then purified 
using the Gel extraction kit. Overlap PCR was performed as stated before (see section 3.1.1). 
Primers pEGFPN1mOtof del C2C PCR1 for and pEGFPN1mOtof del C2C PCR2 rev were used. The 
PCR program is mentioned below. Afterwards the PCR was again loaded on a 1% agarose gel 
and the correct band (size 4047bp) was cut out and purified using the gel extraction kit. 
95°C 5min 















Ligation procedure of overlap product and pBlueScript vector was conducted as previously 
stated. After ligation the whole mix was electroporated into XL1Blue cells and incubated over 
night at 37°C. Colony PCRs were done the next day. 
In case the sequence was correct pBlueScript vector with del C2C insert and pEGFPN1mOtof 
vector were digested using SanDI and EcoRV using 3µl fast digest buffer green as mentioned 
below. Since SanDI was only purchasable as a fast digest enzyme, a fast digest enzyme and a 
normal one were combined. A digestion mixture was prepared using the fast digest buffer 
green, which came with SanDI and had loading dye already included, including all ingredients 
except SanDI. Digestion with EcoRV only was performed for 50min; subsequently SanDI was 
added and incubated at 37°C for another 10-15min.  
Insert 
3µl Fast Digest Buffer green 
1µl enzyme each 




3µl Fast Digest Buffer green 





The digested vector and the produced insert were then ligated together as stated previously. 





Figure 3.5: Depicted are vector maps of pEGFPN1mOtof vector before removing the C2C domain (left) 
and afterwards (right). The used restriction enzymes as well as their location are shown in red; the 
location of the used primers is indicated in purple. The overstretching primer is shown as two parts, 
indicating the part binding upstream and downstream of the C2C domain.   
 
3.1.5 Cloning of pEGFPN1mOtof del C2F 
 
To obtain a deletion construct of mouse otoferlin with a missing C2F domain in the pEGFPN1 
vector the desired sequence was removed using two pairs of designed primers in two adapter 
PCRs followed by one overlap PCR, using the both obtained products from the previous PCRs as 
templates (compare Fig. 3.1). The obtained product was amplified and subcloned into 
pBlueScript using blunt end ligation. The insert was sequenced and in case of a correct 
sequence digested with the enzymes KpnI and SanDI and finally cloned into pEGFPN1 mOtof.  
Two adapter PCRs in a mixture as stated previously were performed as followed. For PCR1 and 
PCR2 primer pairs pEGFPN1mOtof del C2F PCR1, for (ATGTTGACAGTGGCCGTGTA) and 




pEGFPN1mOtof del C2F PCR2, for (GAAGTACGAGAATGAGAATGATGAGTTTGAGC) and 
pEGFPN1mOtof del C2F PCR2, rev (GCTGAACTTGTGGCCGTTTACG) were used, respectively. 
Adapter PCR1  
95°C 3min 






Adapter PCR2  
95°C 3min 





The expected sizes of PCR1 and PCR2 were 544bp and 446bp respectively. The PCR products 
were loaded on a 2% agarose gel, the correct band was cut out and the DNA was then purified 
using the Gel extraction kit. An overlap PCR was conducted as already stated before (see 
section 3.1.1). The used program is mentioned below. Primers pEGFPN1mOtof del C2F PCR1 for 
and pEGFPN1mOtof del C2F PCR2 rev were used. The correct band size (964bp) was confirmed 
on a 1% agarose gel. 
95°C 5min 















Ligation procedure of overlap product and pBlueScript vector was conducted as previously 
stated. After ligation the whole mix was electroporated into XL1Blue cells and incubated over 
night at 37°C. Colony PCRs were done the next day. 
In case the sequence was correct pBlueScript vector with del C2F insert and pEGFPN1mOtof 
vector were digested using KpnI and SanDI using 3µl fast digest buffer green as mentioned 
below. For digestion procedure using one normal and one fast digest enzyme see section3.1.4. 
Insert 
3µl fast digest buffer green 
1µl enzyme each 





3µl fast digest buffer green 




The digested vector and the produced insert were then ligated together. 






Figure 3.6: Depicted are vector maps of pEGFPN1mOtof vector before removing the C2F domain (left) 
and afterwards (right). The used restriction enzymes as well as their location are shown in red; the 
location of the used primers is indicated in purple. The overstretching primer is shown as two parts, 
indicating the part binding upstream and downstream of the C2F domain. 
 
3.1.6 Cloning of constructs containing a point mutation in otoferlin 
 
Generating of constructs with a single point mutation was performed similar to generation of C2 
deletion constructs. Using two pairs of primers in two adapter PCRs, an overlap PCR and 
subcloning steps, a point mutation in the amino acid sequence of otoferlin was inserted. All 
constructs were finally subcloned into pcDNA3 vector. For the generation of pcDNA3mOtof 
R1607W, similar to the generation of pEGFPN1mOtof del C2A only one PCR was necessary. Used 
primers are mentioned in table A2. All constructs could be obtained using similar primers 
For inserting the I515T as well as the G541S mutation two adapter PCRs each were performed 
which programs are shown below. For inserting I515T mutation primer pairs pEGFPN1mOtof 
I515T 1, for (CGTTCATCGGTGAGAACAAG) as well as pEGFPN1mOtof I515T 1, rev 




(ACCCACTTCACCGACCTGCGCAAGATTTCC) and pEGFPN1mOtof I515T 2, rev 
(ACAGAGGCGTGTCAGGATC) were used; for inserting the G541S mutation primer combination 
pEGFPN1mOtof G541S 1, for (CGTTCATCGGTGAGAACAAG) and pEGFPN1mOtof G541S 1, rev 
(GCGTGGAGCTGTACATGTTCACCCAGGCTG) as well as pEGFPN1mOtof G541S 2, for 
(GAACATGTACAGCTCCACGCGCAACTACAC) and pEGFPN1mOtof G541S 2, rev 
(ACAGAGGCGTGTCAGGATC) were used. 
Adapter PCR1  
95°C 3min 






Adapter PCR2  
95°C 3min 





The expected sizes of 220bp and 3329bp for I515T as well as 290bp and 3252bp for G541S were 
confirmed on an agarose gel. DNA was purified and used for following overlap PCR. Primers 
pEGFPN1mOtof I515T 1, for (CGTTCATCGGTGAGAACAAG) and pEGFPN1mOtof I515T 2, rev 
(ACAGAGGCGTGTCAGGATC) were used. 
95°C 5min 














The correct size of 3535bp was confirmed on a 1% agarose gel and the DNA was purified using 
gel extraction kit. For inserting the R1607W mutation no previous adapter PCRs were needed. 
PCR was performed using primers pEGFPN1mOtof R1607W, for (CGTTCATCGGTGAGAACAAG) 
and pEGFPN1mOtof R1607W, rev (TCATGGGGTCCCACCAGATATTGTAGCCATGTATG), mixture 
was as described earlier. 
95°C 3min 






Ligation procedure of overlap product/R1607W product and pBlueScript vector was conducted 
as previously stated. After ligation the whole mix was electroporated into XL1Blue cells and 
incubated over night at 37°C. Colony PCRs were performed the next day. 
In case the sequence was correct, pBlueScript vector with desired mutation and pEGFPN1mOtof 
vector were digested using SanDI and SalI utilizing 3µl fast digest buffer green as mentioned 
below. For digestion procedure using one normal and one fast digest enzyme see section 3.1.4.  
The digested vector and the produced insert were then ligated together. 
In Fig. 3.7 the obtained constructs are shown. The localization of the individual point mutations 







Fig. 3.7: Shown are the obtained constructs after inserting a point mutation as well as their locations in 
otoferlin. 
 
3.1.7 Cloning of pEGFPN1mOtof RXR and pcDNA3mOtof RXR I515T 
 
Inserting of the RXR motif into otoferlin was performed similar to previously explained 
generation of C2 domain deletion constructs. Instead of deleting parts of the nucleotide 
sequence, nucleotides which will later form the RXR motif were inserted using the pair of 




The RXR motif without the I515T mutation was first subcloned into pBlueScript mOtof using SfiI 
and SanDI. From the pBlueScript mOtof vector the insert was cut out using SanDI and SalI and 
cloned into pEGFPN1mOtof. The latter combination consisted of a fast digest and a normal 
enzyme whereas the other pair was composed of two fast digest enzymes. For digestion 
procedure using one normal and one fast digest enzyme see section 3.1.4.  
Since a pcDNA3mOtof vector with the I515T mutation in otoferlin was already generated 
before, a sequence containing the RXR motif was removed from the generated pBlueScript 
mOtof RXR vector and inserted into this already existing construct using SanDI and SfiI. 
For generating pEGFPN1mOtof RXR construct, two adapter PCRs followed by one overlap PCR 
were performed. Programs and mixture of the adapter PCR are shown below. Instead of Pfu 
DNA polymerase to amplify the sequence in PCRs Phusion polymerase was used. For PCR1 
primers pEGFPN1mOtof RXR PCR1, for (CAATGATTGACCGGAAAAATGGGG) and pEGFPN1mOtof 
RXR PCR1, rev 
(CACAGCACACGGCAGCGCCGGAGAAGCCTGACCGTGGTGTTCCAGCTGGGGGCTGAGCGGTCTGG) 
were chosen, for PCR2 primers pEGFPN1mOtof RXR PCR2, for 
(CGGCGCTGCCGTGTGCTGTGCAATGGGGGCTCCTCCTCTCACTCCACAGGGGAGGTTGTAGTAAGC) 











Adapter PCR1  
95°C 3min 







Adapter PCR2  
95°C 3min 








10µl Phusion buffer GC 
0.3µl DNA template 
0,5µl  Primer each 
1.5µl DMSO 




The PCR products were loaded on a 1% agarose gel where the expected sizes of 1904bp for 
PCR1 and 1124bp for PCR2 were confirmed. The correct bands were cut out and the DNA was 
purified. An overlap PCR was conducted as mentioned below. Primers pEGFPN1mOtof RXR 
PCR1 for and pEGFPN1mOtof RXR PCR2 rev were used. The correct band size (3010bp) was 
confirmed on a 1% agarose gel. 
95°C 3min 







9µl cleaned PCR product each 
8µl Phusion buffer GC 
0.8µl dNTPs (0.25mM each) 
1.2µl DMSO 
0.4µl Phusion 









After subcloning of the overlap PCR product into pBlueScript mOtof vector, three constructs 
were sequenced. In case of correct sequence, the insert was cloned into pEGFPN1 mOtof or 
into the already existing pcDNA3mOtof I515T vector using the already mentioned enzymes.  
After ligation the whole mix was electroporated into XL1Blue cells and incubated over night at 




Gel Extraction (Zymoclean™ Gel DNA Recovery Kit, Zymo Research)  
The procedure was done according to the manual. The gel slice was incubated at 55°C until 
completely dissolved; the DNA was resuspended in 10µl H2Odest.  
DNA Clean Up (DNA clean and concentrator™-5, Zymo Research)  
The procedure was done according to the manual. The DNA was mixed at the ratio of 1:5 with 
DNA binding buffer and then resuspended in 10µl H2Odest.  
Plasmid extraction peqGOLD Plasmid Miniprep Kit I (peqlab) 
The procedure was done according to the manual. Plasmid was resuspended in 75µl elution 
buffer (included in kit). 
NucleoBond® PC 100 (Machery-Nagel) 
A single colony was transferred into 50ml LB media supplied with the according antibiotic and 
incubated at 37°C for 16h. The cells were pelleted (Beckmann Coulter® Avanti® J-30I) and 
resuspended in 4ml buffer S1. Buffer S2 was added and the mixture was incubated for 5min at 
RT, then buffer S3 was added and the mixture was incubated on ice for 5min. A column was 
equilibrated using 2.5ml buffer N2. The mix was filtrated; the eluate was transferred to the 
column and filtered. The column was washed using 10ml buffer N3. Using 5ml buffer N5 the 




at 4°C. Plasmid was pelleted (1h, 4°Cm 4000g, Beckmann Coulter® Avanti® J-30I) and washed 
using 600µl 70% EtOH. Dried pellet was resuspended in 75µl elution buffer.    
 
3.3 HEK cell culturing 
 
HEK cells, which were kept in liquid nitrogen for longer storage, were thawed; when the pellet 
was nearly completely melted cells were poured into a 10cm petri dish containing 10ml HEK cell 
medium. The medium was replaced one day later and cells grew until 80-90% confluence. For 
culturing, HEK cells had to be splitted to avoid too high density. Firstly, media was removed and 
cells were washed with 3ml PBS, then treated with 2ml Trypsin and incubated for 5min at 37°C 
for detaching the cells. Trypsin containing the cells was transferred to a 15ml falcon tube and a 
few milliliters of medium were added, then the cells were pelleted (1500rpm, 5min). Cells were 
resuspended in amount of medium depending on the size of the pellet and splitted in new 
dishes at a ratio from 1:5 to 1:20.  
In case a specific amount of cells was needed, cells were counted after centrifugation and 
removing the Trypsin solution. For that between 4ml and 8ml HEK cell medium, depending on 
the size of the pellet, was added and the pellet was resuspended by carefully pipetting up and 
down. Using a Neubauer Counting Chamber cell counted and the quantity of cells in 10µl was 
estimated. The appropriate amount of medium containing the cells was then transferred to a 
petri dish and distributed evenly by shaking movements. 
 
Transfection procedure 
HEK cells were transfected using Lipofectamine 2000. For cells incubated in a 6cm petri dish 8µg 
DNA and 20µl Lipofectamine 2000 were needed. Both DNA and transfection reagent were 




mixed and incubated for another 20min. HEK cell medium was replaced by 5ml DMEM medium 
without supplements and 1ml of the mixture was pipetted to the cells. 
 
3.4 Cycloheximide procedure for HEK cells 
 
Cells were splitted as described above. 1.000.000 cells per 6cm dish were incubated overnight 
for attaching to the surface. On the next day medium was replaced by DMEM medium without 
supplements and cells were transfected using Lipofectamine 2000 (see transfection procedure 
section 3.3), solution stayed with the cells overnight. 14h later cells were treated with 
Cycloheximide in a concentration of 100µg/ml and cells were incubated either at 37°C or at 
38.5°C. Samples were taken at certain time points, namely 0min (control without 
Cycloheximide), 5min, 10min, 20min, 30min, 60min, 2h, 3h, 6h, 9h, 12h and 24h (extended time 
points longer that 2h only for otoferlin WT and otoferlin I515T). Therefore medium was 
removed and cells were washed carefully with 3ml PBS. After removing PBS 100µl Laemmli 
loading buffer was added directly and cells were removed using a cell scraper. The liquid was 
transferred into a 1.5ml tube and all tubes were stored at -20°C until all samples were taken. 
Then samples were thawed and sonified (Branson sonifier: 20% duty cycle, output control 2, 
Bandelin Sonopuls 40% power) for 3x20sec, in between the three steps the samples were 
cooled down to room temperature. After sonification, the samples were ready to load on a gel.  
20µl of each sample were loaded on polyacrylamide gels (see section 3.11) and separated until 
bromophenol band left the gel. The gel was stained using Coomassie blue and destained using 
water until single bands were visible. The gel was then brought to mass spectrometry 
department (Research Group Mass Spectrometry) for further treatment.  
Mass spectrometry data were analyzed using Maxquant program (version 1.5.2.8) by Kuan-Ting 
Pan (Research Group Mass Spectrometry). IBAQ values were determined and normalized to 4 
stable background proteins (Sperm Associated Antigen 9 (Spag9), topoisomerase (DNA) II beta 




(Uba5)).  Those background proteins were present in high abundance across all the samples and 
were stable over the chosen time range. IBAQ values were copied to Microsoft Excel and the 
values of the mutants were normalized to those of otoferlin wild type 
 
3.5 Gene Gun 
 
Generation of Gene Gun bullets 
For the generation of Gene Gun bullets the protocols of Belyantseva, 2009 and Zhao et al., 2012 
were modified. 25mg gold with a diameter of 1µm were mixed with 100µl 0.05M spermidine, 
vortexed for 15sec and sonified for 30sec. 50µg DNA diluted in 50µl H2O were added and the 
solution was vortexed for 5sec. During vortexing, 100µl 1M CaCl were pipetted carefully to the 
mixture. Following was an incubation step of 10min including vortexing steps every 30secs for 
5secs. For pelleting the particles the mix was centrifuged (2min, 1000g) and most of the 
supernatant was removed, the gold particles were resuspended in the remaining liquid. The 
gold particles were washed three times (10sec, 1000g) with 100% EtOH, after the last washing 
step most of the EtOH was fully removed. Gold particles were transferred into a 15ml falcon 
tube using 3ml 50µg/ml PVP, the mixture was vortexed for 15secs. The Tefzel tubing was dried 
at N2 flow of 0.4l/min for at least 15min. After drying the gold particle solution was transferred 
into the Tefzel tubing using a syringe. The gold particles were distributed equally throughout 
the inside of the tubing by several turning steps using the tubing prep station. Using N2 at 0.4-
0.5l/min the Tefzel tubing was dried during constant rotation, afterwards the bullets were cut 
using the provided bullet cutter. 
 
Transfection procedure 
Mice at the age from p3 to p5 were decapitated using sharp scissors. The head was dipped into 




cut in halves from caudal to cranial and the brain was removed carefully using small scissors. 
The back part of each side of the head containing the cochlea and with that the organ of Corti 
was cut off and put into a petri dish with HEPES HANKS solution. Under the sterile bench the 
organ of Corti was removed using forceps of different sharpness and transferred into a culture 
dish with 1ml DMEM/F-12 media supplemented with 10% NBCS. In case the stria vascularis was 
already partially removed during the preparation procedure, it was removed completely. 
Before the Gene Gun transfection, the organ of Corti was flipped upside down with the basilar 
membrane facing up and carefully directed to the middle of the petri dish. The medium was 
removed cautiously and left in the pipette tip. The petri dish was removed from the sterile 
bench and placed under a tripod, two cell strainers with a mesh diameter of 40µm (BD Falcon) 
glued together on top of each other were placed over the organ of Corti (modified from Zhao et 
al., 2012). Using a helium pressure of 200-220psi the gold particles were transferred into the 
organ of Corti. The tissue was placed back under the sterile bench and two milliliters of medium 
were added. The organ of Corti was flipped back and separated into two to three parts. These 
parts were carefully attached to earlier with CellTak coated coverslips and incubated for 48h. 
After that the tissue underwent an immunostaining (see section 3.6, all washing steps were 
performed in petridishes, blocking and antibody incubation took place on coverslips). 
 
3.6 Immunohistochemistry and Immunocytochemistry 
 
Immunostaining procedure of organs of Corti 
Mice at the age ranging from p14-p20 were used for immunostainings. After isolation of the 
cochlea, edge and top of it was removed carefully and a small opening was carved in by 
removing a bit of the cartilage. The cochlea was transferred into a 0.5ml tube and 500µl 4% 
formaldehyde were added for fixation, the tubes were incubated on ice for 1h. All following 
steps were performed under shaking. Several washing steps for at least 30min with PBS 




origin of the secondary antibodies. The primary antibodies diluted in either DSDB or GSDB were 
added and the cochlea was incubated overnight at 4°C. On the next day the preparation was 
washed several times with wash buffer, then according secondary antibodies in a ratio 1:200, 
diluted in GSDB or DSDB, were added. The cochlea was incubated in darkness for 1h and 
afterwards washed in wash buffer including several buffer replacements. After the last washing 
step the cochlea was transferred to a Petri dish containing PBS, the organ of Corti was removed 
carefully and transferred to an object slide. After removing most of the wash buffer, 100µl 
5mM PB was carefully dribbled around the organ of Corti and incubated in darkness 1-5min. 
Afterwards, the liquid was removed and 10µl Mowiol Mounting Medium was dropped on the 
organ of Corti, then it was covered with a cover slip. The preparations were kept in the fridge 
until further study. Used antibodies are displayed in table A4 and Table A5.  
 
3.7 Fluorescence Microscopy and image analysis 
 
Stained organs of Corti were imaged on a Leica SP5 confocal microscope (63x Glycerol 
objective, NA = 1.3, imaging of z-stacks with 0.6-0.8µm step size) using 488mn argon laser and 
594nm DPSS laser. For imaging of PLA and Gene Gun samples an additional 405nm laser was 
used. Distribution of proteins in the inner hair cell was analyzed by a Matlab routine 
implemented in Imaris by Gerhard Hoch (Institute for Auditory Neuroscience). Gene Gun cells 
were stained using α-otoferlin and α-VGlut3 antibodies. The fluorescence was normalized to 
the cellular fluorescence of each fluorophore. Five parallel line scans from apical to basal 
through the middle of the cells were performed. The most basal part of the membrane was set 
manually. It was determined as the most basal point of the cell that exceeds the threshold 
value for the summed fluorescence. The threshold for summed fluorescence was set to 5 for 
Gene Gun transfected cells to quantify the fractional membrane staining of otoferlin. The 
otoferlin-VGlut3 fluorescence value was read out. This value represents the fraction of 
membrane bound otoferlin (for an overview compare Fig. 3.8). Immunostainings were 





Figure 3.8: Shown is a maximum projection of a wild type inner hair cell to illustrate Imaris analysis. Cell 
is stained against otoferlin (magenta) and VGlut3 (green), scale bar is 5µm. Average of five parallel line 
scans of otoferlin is depicted magenta in the graph; average of VGlut3 is depicted in green. The sum of 
both fluorescences is shown as a black line, the blue line shows Otof fluorescence minus VGlut3 
fluorescence. The most basal point is depicted as a yellow diamond, the orange diamond indicates read 
out of otoferlin minus VGlut3, modified from Strenzke et al., 2016). 
 
3.8 Proximity Ligation Assay 
 
To test for possible interaction partners of otoferlin, proximity ligation assay were performed. 
Promising candidates were dynamin and OPA1 since those two proteins were a result from pull 
down assays done by Sandra Meese (Molecular Structural Biology, Ralf Ficner) and Sunit 
Mandad (Bioanalytical Mass Spectrometry Group, Henning Urlaub)). After isolation of a mouse 
cochlea a small hole was cracked into its upper part to allow the solutions to reach the inner 
tissue. The organ of Corti was then fixed on ice for 1h in 4% formaldehyde and blocked in 
normal DSDB for 1h, interrupted by several washing steps with PBS. Antibodies for otoferlin in 
combination with either dynamin 1/2/3 or OPA1 were diluted in DSDB without Triton-X-100 
and incubated shaking at 4°C overnight. In addition to the antibodies which should lead to a 
PLA signal, a co-staining with α-calbindin to stain the inner hair cells was performed. All 
following incubation steps were conducted under gentle shaking in a wet chamber at 37°C; 
following washing steps were performed under gentle shaking at room temperature. 
On the next day the two PLA probes were diluted at a ratio of 1:6 in DSDB without Triton and 




the incubation time of the two PLA probes, samples were washed in provided Wash Buffer A, 
solution was changed at least four times. PLA solution on cochleae was incubated for 90min. 
Afterwards, PLA solution was removed and the samples were washed in Wash Buffer A for 
20min. Subsequently ligase solution at a ratio of 1:5 in H2Odest was given to the samples and 
preparations were incubated for 1h. After incubation in ligase solution, samples were washed 
again for 30min in Wash Buffer A including several buffer replacements. The organ of Corti was 
isolated from the cochlea using Buffer A instead of HEPES HANKS. The tissue was transferred 
carefully into a well of a 24-well plate and treated with polymerase at a rate of 1:80 in diluted 
amplification stock at a ratio of 1:5. The mixture was incubated for 100min. After removing of 
amplification solution the organ of Corti was washed for 20min in Wash Buffer B and 
subsequently washed for up to 5min in 0,01x Wash Buffer B, all steps included several buffer 
replacements. Organs of Corti were then mounted on object slides using provided DAPI 
mounting medium, the edges of the cover slips were sealed with nail polish. The earliest after 
15min the slides could be analyzed by fluorescence microscopy. For a short glimpse Axiovert 40 
CFL with HBO 50 lamp from Zeiss was used, for a more intense analysis samples were imaged 
using SP5 microscope from Leica. 
 
3.9 RNA-isolation and generation of cDNA from organs of Corti 
 
Organs of Corti were isolated, beyond the age of p14 at least two mice were needed, at the age 
from p6-p8 one mouse was sufficient. The tissue was transferred into a 1.5ml reaction tube and 
incubated on ice until all organs were isolated. For the mentioned amount of tissue 800µl 
TRIZOL (Invitrogen) were added, the mixture was transferred into 1ml Wheaton homogenizer 
and homogenized carefully avoiding bubbles. Subsequently the homogenized liquid was 
transferred into a 1.5ml tube and incubated for 5min at RT. 160µl chloroform were added and 
the tubes were shaken by hand strongly. After another incubation step of 3min at RT the 
composition was centrifuged for 15min, 13300rpm and 4°C. After that step the upper phase 




mixing carefully the tubes were incubated for at least two hours, better overnight, at -18°C to 
precipitate the RNA. After pelleting of RNA (45min, 13300rpm, 4°C) a washing step with freshly 
prepared 75% EtOH followed (12min, 13300rpm, 4°C). The pellet dried at RT nearly completely 
and was then resuspended in 13µl RNAse free water. The mix was incubated for 10-15min at 
55-60°C and, if needed, stored at -80°C.  
For reverse transcription 13µl of RNA solution were used and incubated for 1min at 55°C. 
Following components were then added 
0.65µl oligo dT primers (50 pmol/µl) 
0.4µl  Random Hexamers (biomers.net; 0.5 µg/µl) 
1.3µl dNTPs (10mM each) 
 
and incubated for 5min at 65°C, samples were then kept on ice. The following components 
were added: 
5.3µl 5x first strand buffer 
5.6µl 0,1M DTT (final concentration 1 mM) 
1.3µl RNAse out (1.8U) 
1µl SuperScript II (260 U) 
 






For precipitation of cDNA 1µl glycogen, 2.3µl 3M NaAc and 76µl 100% EtOH were added, gently 




After precipitation the cDNA was pelleted (60min, 13300rpm, 4°C) and subsequently washed 
with 100µl 75% EtOH (10min, 13300rpm, 4°C). After drying the pellet was suspended in 25µl 
H2Obidest.  
 
3.10  Real-Time PCR 
 
Real-Time quantitative PCR was performed on cDNA of organs of Corti from p9 wild type and 
OtofI515T/I515T mice, all pipetting steps were done using filter tips to avoid contamination. 
Taqman assays were used to perform Real-Time PCR, Mm00453306 (Applied Biosystems) for 
amplification of otoferlin, Mm00446873_m1 for TATA binding protein (TBP) and 
Mm00464451_m1 for bassoon on 2 µl of cDNA solution each. The cDNA is amplified 
comparable to a normal PCR; additionally the amount of cDNA is quantified after every cycle. 
The amount of otoferlin was compared to either TBP or bassoon. To ensure perfect mixing of all 
ingredients, two mastermixes were made. 
Mastermix I  
12.5µl 2x Taq-Man MasterMix 
2µl Template 
 
Mastermix II  
1.25µl 20x Primermix  
9.25µl H2Obidest 
Additionally to every sample, a negative control containing water instead of DNA was carried 
out. After pipetting both mixes in a well of a 96-well plate the top was covered with a self-
sticking foil to avoid evaporation, subsequently the plate was shortly centrifuged (1000rpm, 
3min). All experiments were performed in triplicates.   
The mRNA level of OtofI515T/I515T in comparison to wild type mice was analyzed by the ΔΔCt-
method. With that approach the amount of transcript is indicated as a multiple of the reference 
sample, here otoferlin cDNA from wild type mice. Firstly, different cDNA concentrations of the 




or bassoon as an inner hair cell protein. Ct values from experiments with same DNA and same 
primers were averaged by calculation of a linear value from Ct values from 
Lin(Ct) = 2^(42-Ct ) 
This is based on the assumption that a single DNA molecule results in a Ct of 42 although 
deviations from 42 do not change the overall result. Values of Lin(Ct)  are averaged and back 
calculated, to “real” Ct values using the following form: 
Ct = 42 – LN(Lin(Ct))/LN2 
The value of 42 is eliminated. The now gotten averaged Ct values can now be used to calculate 
Ct values for each tissue sample using 
Ct = Ct(Otof) – Ct(TBP). 
Ct values from individual cDNA preparations were averaged by the calculation of a linear value 
of Ct which was averaged and back calculated as above. Relative mRNA amount which 
compares to the amount of cDNA in wild type and OtofI515T/I515T mice is calculated by  
Ct = Ct (mutant) – Ct (wt) 
and relative Otof mRNA amount = 2^-Ct. 
 
3.11  Polyacrylamide gels and Western Blot of HEK cell lysates 
 
Western Blot procedure (according to Towbin et al., 1979) 
To isolate and separate proteins from HEK cells, SDS PAGE and western blot were performed. 
HEK cells were harvested and processed as already described before (see section 3.4). Gels 
consisted of 6% acrylamide running gel and 5% acrylamide stacking gel (see section 2.7). The 




slots were removed carefully. For experiments 20µl sample and 6µl of prestained marker were 
pipetted into the gel slots. The electrophoresis was performed at 80V until the bromophenol 
band was just leaving the gel. The stacking gel was removed and the proteins were 
subsequently blotted onto a nitrocellulose membrane. The blot chamber containing the blot 
sandwich and transfer buffer was placed inside a box filled with crushed ice to prevent too 
much heat and thus destroying the proteins. The procedure was optimized to a blotting time of 
2h at 250mA. After the blotting procedure the membrane was stained using Poinceau S to 
control the protein transfer. The membrane was blocked for 30min in blocking solution with 
several changes of solution. Afterwards the primary antibodies (mOtof 1600, rb α-β-Actin 
1:6000, rb α-Tubulin 1:2500, rb α-GFP 1:1000), were diluted in blocking solution and incubated 
over night at 4°C under shaking. Next day the membrane was washed with PBS to remove 
unbound primary antibody and subsequently treated with horse radish peroxidase coupled 
secondary antibody diluted in blocking solution (1:5000). The membrane was incubated for 1h 
under shaking. After several washing steps with PBST the membrane was developed using a 
two component system (Pierce® ECL Plus Western Blotting Substrate, Thermo Scientific). 
Developing time was 10min in total, a picture was taken every 30secs and the luminescence of 
every picture was summed up. 








4.1 The mRNA level in OtofI515T/I515T mice is not reduced 
compared to wild type mice 
 
A single point mutation changing isoleucine to threonine leads in humans to temperature 
sensitive hearing loss. At normal body temperature patients have already impaired speech 
recognition but almost normal pure tone hearing (Varga et al., 2006a). An increase in body 
temperature by as little as 1°C, for example during sports or fever, leads to severe to profound 
deafness. The reason for that phenotype is not yet understood. A mouse line was generated 
carrying the named mutation to investigate the reason for temperature dependent hearing loss 
(Strenzke et al., 2016). At normal body temperature otoferlin protein levels are reduced by 65% 
what made us wonder if a reduced mRNA level could be the reason. In combination with a 
maybe less stable version of the protein this could lead to an otoferlin amount below a certain 
threshold. First I checked whether the amount of RNA of both wildtype otoferlin and the 
mutated form differs. For that a quantitative Real-Time PCR was performed, using the organs of 
Corti from wild type and OtofI515T/I515T mice. In the first run primers for otoferlin and for TBP 
were used, in the second run instead of TBP primers bassoon as an inner hair cell protein was 
measured. Amounts of otoferlin mRNA were normalized to either TBP or bassoon (compare Fig. 
4.1). TBP is a stable housekeeping gene which is constantly expressed, bassoon is localized in 





Figure 4.1: Results of quantitative Real-Time PCR. Numbers above bar graphs show count of used mice. 
Left in blue is otoferlin normalized to TATA-binding-protein, right in red is otoferlin normalized to 
Bassoon as an inner ear protein. 
 
Although for OtofI515T/I515T mice the organs of Corti of only two mice were used compared to 
three organs of Corti coming from wildtype mice the results are still useful. The amount of 
mutated otoferlin is not decreased as expected but in contrast slightly increased compared to 
wild type otoferlin.  
 
4.2 HEK cells were transfected with otoferlin constructs 
 
Transfected HEK cells express wild type otoferlin 
HEK cells up to passage 25 were used for transfection experiments. Cells were either 
transfected with wildtype otoferlin or with a deletion construct with one C2 domain missing. 
Cells transfected with wildtype otoferlin functioned as a control. Since the transfected vector in 
addition to otoferlin also contained GFP, that protein was also stained and functioned as a 
transfection control. For immunostainings N-terminal otoferlin antibody from Abcam and GFP 




an otoferlin/GFP fusion construct. The protein is expressed and distributed through the cell. 
Since otoferlin and GFP are not separated, the GFP staining excludes the nucleus. 
 
Figure 4.2: Staining of HEK cells transfected with wildtype otoferlin. Left row shows merged images, 
middle row shows control GFP staining, right row shows otoferlin staining.  
 
Staining of cells transfected with otoferlin deletion constructs 
Cells were transfected with different otoferlin deletion constructs and incubated until satisfying 




Disregarding from cells transfected with otoferlin del C2C cells look comparable among each 
other. Also compared to cells transfected with otoferlin wildtype no severe difference is 
detectable. 
For cells transfected with otoferlin del C2C the GFP staining was normal but no otoferlin staining 
was detectable. It seems that the Abcam α-otoferlin antibody binds in the C2C domain and 
could therefore not detect otoferlin when this domain was deleted.  
 
Figure 4.3: Pictures showing immunofluorescence stainings of HEK cells transfected with different 
otoferlin deletion constructs stained against otoferlin and GFP. Top row shows merged images, bottom 
row shows otoferlin staining alone. A) HEK cells transfected with otoferlin del C2A B) HEK cells 








4.3 Western Blots with transfected HEK cell lysates  
 
In addition to staining of transfected HEK cells an amount of 1.000.000 cells were used for 
generating cell lysates for Western Blot. Cells were transfected with wildtype otoferlin, either 
as a fusion construct between otoferlin and GFP (otoferlin w/o SC, compare also Fig. 4.2) or as a 
construct with a stop codon in between (otoferlin + SC), leading to two separated proteins. 
Furthermore, HEK cell lysates transfected with otoferlin constructs with a missing C2 domain 
were used. After blotting, the membrane was treated with C-terminal otoferlin antibody 
(SynapticSystems) which did not show any signal. After treatment with N-terminal α-otoferlin 
(Abcam) and α-GFP antibody clear bands at the size of otoferlin (~230kDa) and fainter bands at 
the size of GFP (~55kDa) were visible. In the lane with cells transfected with otoferlin del C2C no 
otoferlin band is visible but a band at the size of GFP (compare Fig 4.4).  
 




4.4 Immunostainings of organs of Corti from HA sumo mice 
 
An occurring mutation in the C2F domain of otoferlin is the so called pachanga mutation which 
mutates a possible sumoylation site. For that reason I wanted to test whether otoferlin is 
sumoylated or not. I performed immunofluorescence stainings of His6-HA-SUMO1 (kind gift of 
Marilyn Tirard, Max-Planck-Institut für experimentelle Medizin, Göttingen) (compare Fig. 4.5). 
In this mouse line sumoylations have a hemagglutinin (HA) taq which makes it possible to check 





Figure 4.5: Projection of single slices of immunofluorescent stained inner hair cells from His6-HA-
SUMO1. Top stained against otoferlin and hemagglutinin, bottom hemagglutinin staining alone. 
 
The stainings revealed that sumoylations can be found in the nuclei as expected but not 




4.5 Proximity ligation assay to check for possible interaction 
partners of otoferlin 
 
Not much is known about otoferlin interaction partners. To identify possible candidates a pull 
down assay using brain lysate and a His/Strep tagged C2ABC protein was done (Sandra Meese, 
Department of Molecular Structural Biology, Göttingen and Sunit Mandad, Bioanalytical Mass 
Spectrometry, Göttingen) and revealed, amongst other proteins, dynamin and OPA1. To 
strengthen the hypothesis of an interaction partner I performed proximity ligation assays (PLA). 
This immune based assay results in a fluorescent signal when the two PLA probes, which are 
coupled to the secondary antibodies, bind in a distance of 40nm or less. To make it easier to 
find the inner hair cells in the mounted organ of Corti, Phalloidin or α-calbindin antibody was 
added. In the mounting medium DAPI was included which stains the nuclei. Different 
combinations of antibodies were used as well as otoferlin in combination with α-OPA1 and α-
dynamin 1/2/3.  
Those four antibody combinations bound to proteins which are either interacting, in a proximity 
closer than 40nm or are even the same protein (mCtBP2 + rbCtBP2, mOtof + rbOtof) and were 
for those reasons planned as positive controls. Since those proteins are only present in the cells 
it was anticipated that the signals will be restricted to the cells what is obviously not the case 





Figure 4.6: Shown are three different PLAs, each additionally stained with α-calbindin (green) and DAPI 
(blue), the antibody pair for a PLA signal is indicated in the pictures. 
 
Nevertheless, in Fig. 4.7 it is shown that for every used antibody pair indeed signals can be 
found inside the cell. That we also have signals outside or between cells is maybe due to one 
poor of the two antibodies so that they are not always binding properly and not leading to a 
reliable signal. 
 
Figure 4.7: Enlarged cutouts from PLA control pictures showing that with every used antibody pair some 





Anyway, I felt positive about going on and using PLAs for finding possible interaction partners of 
otoferlin using α-OPA1 and α-dynamin 1/2/3 antibodies. 
Proximity ligation assays with otoferlin and dynamin results in fluorescent spots disregarding 
the used K+-concentration and the incubation temperature 
For otoferlin together with dynamin as well as otoferlin with OPA1 the hypothesis was that 
during stimulation of exocytosis of the sample more proteins interact which should lead to 
more fluorescent spots. So the sample was treated with three different solutions differing in 
their K+-concentration. The inhibitory solution contained fewest K+ (5mM) whereas the long 
excitatory solution contained the most (50mM). In between these two values was the mild 
excitatory solution (40mM).  
In all samples red signals indicating close proximity of otoferlin and dynamin are visible. The 
hypothesis was that the amount of signals differs according to the applied Ca2+-concentration. 
Just looking at the pictures revealed that the number of fluorescent spots does not differ as 
much as expected. Instead of an antibody for Calbindin I used Phalloidin which is not staining 
the entire hair cell but only F-Actin rich regions. For that reason it cannot be said if the signals 
are restricted to inner hair cells or if they are also in between cells as it was in the controls. The 






Figure 4.8: Shown are three PLAs performed in different solutions (from top to bottom 5mM K+, 40mM 
K+, 50mM K+). A single inner hair cell is circled in white. 
 
Further I wanted to know if the incubation temperature has any influence on the proximity of 
otoferlin and dynamin, so I incubated samples in 40K+-solution at room temperature as well as 
37°C. The most spots were expected for 37°C in combination with the mild stimulation solution, 
the fewest when organ of Corti was treated with inhibitory solution. By looking at the different 
pictures it is visible that signals are not equally distributed through the sample, at some spots a 
lot signals seem to cluster together whereas at other parts no spots could be detected. This is 




experiments with different solutions (compare Fig. 4.8), made me decide that this antibody 
combination will not lead to reliable results. That´s why I decided to go on with PLAs using 
otoferlin and OPA1. 
 
 
Figure 4.9: Shown are three PLAs performed in inhibitory or mild stimulation solution and either at room 







Proximity ligation assay of otoferlin and OPA1 results in fluorescent spots 
PLAs performed in the inhibitory solution lead to only very few signals which are mostly not 
inside the cells but between them. However, more signals can be found in cells stimulated with 
the mild excitatory solution. Again, some signals are inside the cells and some are in between 
them. 
PLAs were performed with an α-Calbindin staining additionally and in inhibitory as well as in 
mild excitatory stimulation solution. Results of those experiments are shown in Fig. 4.10. 
 
Figure 4.10: Shown are two PLAs of otoferlin and OPA1 performed in different solutions (5K+ on top, 





Figure 4.11: Enlarged cutout of PLAs performed with α-otoferlin and α-OPA1 antibodies. Signals can be 
found in the cells as well as between them. 
 
Same as already seen in the controls, signals could be observed in the cells as well as between 
them.  
Since PLAs did not show reliable results and it turned out in the meantime by yeast two-hybrid 
experiments (performed by Sarah Helfmann, InnerEarLab, Molecular Biology of Cochlear 
Neurotransmission), that neither OPA1 nor any dynamin seemed to interact with otoferlin I 







4.6 Measuring the reduction of wild type and mutated otoferlin 
protein over 2h via mass spectrometry showed little 
difference 
 
A few point mutation in otoferlin, namely I515T, G541S, G614E,R1080P, R1607W and E1804del, 
lead to temperature sensitive hearing loss. The reason for deafness occurring with elevated 
body temperature is not yet clear and since every mutation is located throughout the whole 
protein it is very unlikely that all have the same cause. One hypothesis was that the mutation 
makes one or more of the mutated proteins instable and it is degraded faster over time. I 
blocked the protein biosynthesis using Cycloheximide so that no new protein could be 
synthesized. Because of the reason that patients with any of those mutations become deaf 
within a very short time span as soon as the body temperature rises I decided to examine 
degradation over 2h at 37°C and 38.5°C using mass spectrometry. The amount of otoferlin was 
compared to stable background proteins, namely Spag9, Top2b, Brd4, and Uba52, which were 
chosen in cooperation with Kuan-Ting Pan (Research Group Mass Spectrometry, Max Plank 
Institute for biophysical chemistry, Göttingen). In addition to the mentioned mutations I also 
analyzed otoferlin with the pachanga mutation which results in lesser protein compared to the 
wildtype and complete deafness. Although it was planned to also investigate cells transfected 
with cDNA of otoferlin E1804del this did not work out due to transfection problems. After 
transfecting HEK cells with that cDNA cells tended to die or grew very slow. The mutations 
G614E and R1080P were not tested at all. 
Shown in Fig. 4.12 is the amount of wildtype otoferlin either at 37°C or at 38.5°C. Higher 
temperature in this figure as well as in the next is always displayed in darker red. After two 
hours of incubation the amount did hardly change which shows that otoferlin seems to be more 
stable than expected. At every measured time point the amount of wildtype otoferlin at 37°C is 






Figure 4.12: Degradation of wildtype otoferlin at 37°C and 38.5°C over 2h after CHX treatment 
 
In Fig. 4.13 the protein quantity of the four used muted forms of otoferlin is shown always 
compared to wildtype otoferlin in red at 37°C and darker red at elevated temperature (same 
color code as Fig. 4.12). The amount of protein in all mutants was normalized to the amount of 





Figure 4.13: Displayed are the results of mass spectrometry data over 2h in four bar graph charts, each 
showing the normalized intensity of wildtype otoferlin (in red) and one temperature sensitive (I515T, 
G541S, R1607W) or pachanga mutation. Error bars show SEM, n=3 
 
The amount of otoferlin carrying the I515T mutation, shown in yellow colors, does neither 
change much in the investigated time range nor is it lower compared to levels of not mutated 
otoferlin. Anyway, the amount of this mutated otoferlin form is always comparable to wild type 
otoferlin. A trend to a decreased level after two hours can be adumbrated. The normalized 
intensity after 2h for 37°C and 38.5°C is 101.2 and 94.1 respectively. 
Shown in purple colors is the amount of otoferlin protein with the G541S mutation. A trend 
towards slightly lower levels at 37°C compared to elevated temperature could be seen but 
taking the error bars into count it cannot be proven. Comparing the amount to wild type 
otoferlin levels no drastic change could be observed. The normalized intensity after two hours 




The amount of protein carrying the pachanga mutation is shown in green colors. Same as for 
otoferlin with the G541S mutation, the quantity of protein with the pachanga mutation seems 
to be lower without looking at the error bars. But giving consideration to those the change is 
not drastically and the amount of mutated otoferlin is again comparable to the wild type form. 
The normalized intensity after two hours of incubation is 85.9 and 82.4 for 37°C and 38.5°C 
respectively. 
The amount of otoferlin carrying the R1607W mutation is displayed in blue colors. The amount 
of mutated otoferlin at 38.5°C is over the investigated time comparable to those at 37°C. In 
addition the amounts of otoferlin with the R1607W mutation is comparable to wild type 
otoferlin over the two hours of incubation. The normalized intensity after two hours of 
incubation is 96.4 and 89.2 for 37°C and 38.5°C respectively.  
Taken together I showed that none of the tested mutated forms of otoferlin degrades rapidly, 
hinting that fast degradation at elevated temperature does not seem to be the reason for 
temperature sensitive hearing loss. Nevertheless I was interested on the behavior of mutated 
forms of otoferlin at elevated temperature, so I performed another set of HEK cell transfection 
with cDNA of wild type otoferlin and carrying the I515T mutation with incubation time over 
24h. 
 
4.7 Measuring the reduction of wildtype otoferlin and otoferlin 
I515T protein over 24h using mass spectrometry showed 
little difference 
 
Since otoferlin was not drastically degraded after 2h of incubation, I decided to incubate 
wildtype and otoferlin I515T transfected cells for up to 24h to have a good hint on possible  
degradation mechanisms as well as half life time. The other mutations were left out because 




Experiments were conducted as previously, medium of HEK cells with satisfying confluency was 
supplemented with 100µg/ml Cycloheximide and cells were incubated at either 37°C or 38.5°C. 
The results (see Fig. 4.14) show that after 24h incubation protein levels neither of otoferlin 
wildtype nor of otoferlin I515T changed as we expected.  
 
Figure 4.14: Results of mass spectrometry analysis of otoferlin wildtype and otoferlin I515T mutation 





Protein levels of otoferlin wildtype incubated at elevated temperature comparably to otoferlin 
protein levels from 37°C, if anything showing a slight trend towards higher levels. Otoferlin 
I515T protein levels also did not show great reduction and only irrelevant differences between 
different temperatures could be determined. Compared to wildtype otoferlin protein levels, 
protein levels of the mutated form are comparable as well.   
 
4.8 Differences between mouse and human otoferlin 
 
Verification of the otoferlin form present in mouse organs of Corti 
So far it was never checked for the otoferlin sequence in mouse organs of Corti by experiments. 
In public databases several sequences could be found like RefSeqs (reference sequence) variant 
1, variant 2 or several computed mRNA sequence of predicted otoferlin isoforms, one of those 
was congruent with the otoferlin cDNA subcloned in our lab from organ of Corti cDNA. 
Alignment of the two RefSeq variants and our lab clone showed that in variant 1 a short amino 
acid stretch is present whereas it is absent in the other two isoforms (compare Fig. 4.15 A). I 
generated cDNA from mouse organs of Corti and performed a PCR using primers which bind 
upstream and downstream of amino acid 168, the sequence under question. After agarose gel 
electrophoresis (compare Fig. 4.15 C) I expected a band either of the product size of 155bp for 
transcript variants 2 and cochlear otoferlin or 200bp for variant 1. The PCR reveals an intense 
band at the size of the smaller product. 
 
Mouse otoferlin lacks one amino acid stretch witch is present in humans 
Patients carrying the otoferlin I515T mutation already have a severe hearing phenotype at 
normal body temperature and become deaf rapidly when the body temperature rises. 
However, mice having the same mutation in otoferlin are not deaf at elevated body 




and human otoferlin explaining that. A CLUSTAL 2.1 alignment was made including otoferlin of 
different species and three variants of mouse otoferlin (compare Fig. 4.15 B). Using cDNA of 
mouse organs of Corti a PCR was performed using primers binding upstream and downstream 
of amino acid 1242 in mouse variant 4. This results either in a product size of 148bp for variants 
1 and 4 or 208bp for transcript variant 2. The PCR reveals an intense band at the size of the 
smaller product (compare Fig. 4.15 C). 
 
Figure 4.15: Shown are sequence variations of otoferlin across different species and three different 
mouse variants (Human otoferlin, NP_001274418.1; Bos Taurus, NP_001137579.1; Mus musculus 
transcript variant 4, NM_001313767.1 (cDNA used in our experiments); Mus musculus transcript variant 
1, NP_001093865.1; Mus musculus transcript variant 2, NP_114081.2; Xenopus, XP_012826776.1, Gallus 
gallus, XP_004935917.1)(Strenzke et al., 2016). A) The presence of the amino acid stretch 
A 
human          163 PGEKSFR---------------RAGRSVFSAMKLGKNRSHKEEPQRPDEPAVLEMED 204 
bos            163 SGEKSFR---------------RAGRSVFSAMKLGKNRPHKEEPQRQDEPAVLEMED 204 
rat            163 PGEKSFR---------------RAGRSVFSAMKLGKTRSHKEEPQRQDEPAVLEMED 204 
mouse var2     162 SGEKSFR---------------RAGRSVFSAMKLGKTRSHKEEPQRQDEPAVLEMED 203 
mouse var4     162 SGEKSFR---------------RAGRSVFSAMKLGKTRSHKEEPQRQDEPAVLEMED 203 
mouse var1     162 SGEKSFRSKGREKTKGGRDGEHKAGRSVFSAMKLGKTRSHKEEPQRQDEPAVLEMED 218 
Xenopus        173 SGERAFK---------------RVGKGVFSAMKLGKTRPPKDESRKQDEPAVLETED 215 
gallus         172 STERSFR---------------RAGKGVFSAMKLGKARPTKDDHRKQDEPAVLEAED 214 
                   . *::*:               :.*:.********* *. *:: :: ******* 
 
                                
B 
 
human           1234 PDRSAPSWNTTVRLLRRCRVLCNGGSSSHSTGEVVVTMEPEVPIKKLETMVKLD 1287 
bos             1234 PDRSAPNWNTSGRLLQGRRGLYSGGPSSRLTGEVVVSMEPEVPIKKLETMVKLD 1287 
rat             1234 PDRSAANWNTTVRLLRGYHMLCNGGPSSCPTGEVVVSMEPEVPVKKLETLVKLD 1287 
mouse var2      1233 PDRSAPNWNTTVRLLRGCHRLRNGGPSSRPTGEVVVSMEPEEPVKKLETMVKLD 1286 
mouse var4      1233 PDRSAPNWNT--------------------TGEVVVSMEPEEPVKKLETMVKLD 1266 
mouse var1      1248 PDRSAPNWNT--------------------TGEVVVSMEPEEPVKKLETMVKLD 1281 
Xenopus         1246 PDKNSQQWTTAAKLMNGYLAMTNGRPRSRTTGEIVINMEPEAPVKKMETMVKLE 1299 
gallus          1245 PDKKAQHWN--------------------MTGEIIVNMEPEVPIKKMETMVKLE 1278 











20  bp 







SKGREKTKGGRDGEH was tested via PCR and agarose gel electrophoresis (compare C). For amplification 
of the SKG-sequence primers pEGFPN1mOtof del C2B PCR1, for and pEGFPN1mOtof del C2A rev were 
used. B) The sequence between C2D and C2E was tested for presence or absence of an arginine-rich 
domain including a RXR-motif using PCR and agarose gel electrophoresis (compare C). Primers 
TCATCTACCGACCTCCAGACC and CACATCCACCTTGACCACAGC were used. C) Agarose gel of mentioned 
PCRs with mouse organ of Corti cDNA from A and B.  
 
Taken the results of the two PCRs together it seems that mouse cochlear otoferlin misses an 
amino acid stretch around amino acid 168 (SKGREKTKGGRDGEH) (compare Fig. 4.15 A) as well 
as a stretch present in human (compare Fig. 4.15 B). Based on these results a new entry to 
public DNA databases was generated which was named mouse variant 4 (NM_001313767.1). 
 
4.9 Biolistic transfection of inner hair cells using different 
forms of otoferlin 
 
Optimizing Gene Gun transfection 
Regarding age of used mice, diameter of used gold particles (0.6µm, 1µm, 1.6µm), time of 
incubation after transfection, used pressure and orientation of organ of Corti the whole 
procedure had to be optimized. For the optimizing procedure I transfected wildtype mice with a 
construct containing GFP alone. It turned out that transfection with the smallest gold particles 
lead to very stable but only very few transfected cells and transfecting with particles of 1.6µm 
in diameter lead to a lot transfected cells of which unfortunately a lot died within a day. 
Transfecting cells with gold particles of 1µm in diameter lead to results in between which was 
the reason why that size was chosen for further experiments.  
To find the perfect age of mice for transfection it was started with young mice ranging between 
p2 and p8. It was anticipated that younger mice are easier to transfect and that more tissue 
could be removed from the cochlea. It turned out that mice at the age of p5 and older were 




However, p4 mice showed more transfected cells than the other mice tested, the fluorescent 
was in addition stable for up to four days and cells seem to be less destroyed. All the further 
transfection experiments were conducted with p4 mice. 
Transfected organs of Corti were incubated for up to four days to ensure stability of GFP signals 
in the transfected cells. Daily a few organs of Corti were fixed and stained against GFP and 
VGlut3. Although not all cells survived the transfection even after four days of incubation cells 
in a good condition were visible. In the end it was decided to incubate cells for two days, if cells 
after immunofluorescence staining did not look healthy they were not taken into count for the 
analysis. 
In the first time of the optimizing procedure I tried to transfect inner hair cells by applying the 
shooting pressure from above. It turned out that most of the gold particles at low pressure (20-
50psi) were not able to pass the tectorial membrane and according to that were not able to 
transfect the cells. The few transfected cells were no inner hair cells and even increasing the 
pressure rather lead to a damaged organ of Corti than to a sufficient amount of transfected 
cells. It was tried if flipping the organ of Corti after isolation and before transfection would lead 
to sufficient results. It turned out, that after increasing the pressure to ~210psi a satisfying 
amount of inner hair cells was transfected. 
To ensure always the same distance between Gene Gun and tissue a self-made tripod with 
expendable legs was used. The distance between Gene Gun nozzle and organ of Corti could be 
adjusted to 4cm, 3cm, or 2cm. To keep the stress as low as possible and because it lead to 
transfected cells I decided to use a distance of 4cm. 
The last optimizing step was performed together with Hanan Al-Moyed (Molecular biology of 
cochlear neurotransmission group). We tried to reduce the effective pressure on the tissue but 
ensure enough gold particles to transfect the cells. For that we tested different combinations of 
cell strainers with varying diameters or also single cell strainers (BD Falcon). It turned out that 
two 40µm cell strainers, one glued on top of the other, resulted in the best results. We 




To sum it all up I used for all my Gene Gun experiments gold particles with a diameter of 1µm, 
mice at four days of age and two days of incubation at 37°C after transfection. Cells were 
transfected after flipping the organ of Corti and using a pressure of ~210psi, the distance 
between tissue and Gene Gun nozzle was ensured by using a tripod, the pressure was 
minimized by using two 40µm meshes. For a better understanding of the experimental set up 
compare Fig. 4.16.  
 







Comparing cells of wild type mice and Otof-/- transfected mice shows comparable distribution 
of otoferlin 
After optimizing of the whole transfection procedure regarding age of mice, size of gold 
particles, time of incubation after transfection, orientation of organ of Corti for the transfection 
process and incubation duration after transfection, I first started by transfecting organs of Corti 
of Otof-/- mice with cDNA of unaltered otoferlin and compared the protein distribution to those 
of wild type mice.  
Transfected organs of Corti as well as tissue from wild type mice were incubated for two days 
after transfection or isolation respectively to allow on the one hand transfected cells the 
expression of the new cDNA and on the other hand attaching of the tissue to the cover slips. 
After that, immunostainings for VGlut3 and otoferlin were performed and the distribution was 
distinguished using Imaris software implemented by Gerhard Hoch (Institute for Auditory 
Neuroscience). Imaris is a MATLAB based routine which allows it to measure the distribution of 
fluorescence through an inner hair cell. The routine for that analysis was developed by Gerhard 
Hoch (Institute for Auditory Neuroscience) and Hanan Al-Moyed (Molecular Biology of Cochlear 
Neurotransmission) and adapted by me for my experiments. The cell was encircled and the 
nucleus as well as the most basal part of the cell was marked manually. Subsequently a vector 
was drawn, bisecting the cell into half from apical to basal. Along that vector five parallel line 
scans were performed. The marked basal point was determined as the most basal point of the 
cell that exceeds the threshold value for the summed fluorescence. The threshold for summed 
fluorescence was set to 5 to quantify the fractional membrane staining of otoferlin. The 
otoferlin-VGlut3 fluorescence value was then read out and represents the fraction of 
membrane bound otoferlin (compare section 3.7) 
In wildtype cells it is clearly visible that otoferlin is localized in the membrane whereas VGlut3 is 
not. This was the distribution I was expecting for Gene Gun transfection as well. Staining and 
comparison of transfected and wild type cells showed that the distribution is a little different 
(compare Fig. 4.17). Otoferlin membrane staining in transfected cells is not as strong as in 




go on with further transfection experiments with modified otoferlin cDNA. For exemplary 
immunofluorescence staining compare Fig. 4.17. Imaris analysis is shown in Fig. 4.18. 
 
Figure 4.17: Comparison of wild type inner hair cells and with otoferlin cDNA transfected Otof-/- cells via 
Gene Gun. A) Organs of Corti were transfected with wild type cDNA of otoferlin and GFP by Gene Gun. 
Left images show merge of both channels, left shows otoferlin staining alone (B) stained inner hair cells 






Figure 4.18: Different graphs showing the results of Imaris analysis, comparing wild type otoferlin 
transfected cells and cells from wildtype mice. Error bars show SEM. WT=wildtype, GG=Gene Gun. n=6 







Otof-/- cells transfected with otoferlin RXR still show otoferlin membrane staining 
disregarding the incubation temperature 
Because of the difference in sequence between mouse and human otoferlin, mouse otoferlin is 
missing the arginine rich amino acid stretch containing an RXR motif (compare section 4.8), we 
wanted to know whether this stretch leads to a difference in membrane localization of 
otoferlin. For that we transfected organs of Corti and incubated them either at 37°C or 
additionally at 38.5°C for 30min feigning elevated body temperature. No matter at which 
temperature the cells were incubated, we did not observe an influence on the membrane 
localization of otoferlin in immunofluorescence stainings. Same as in Otof-/- transfected cells 
membrane staining is still visible (compare Fig. 4.19).  
Evaluation of the Imaris analysis (compare Fig. 4.20) revealed that otoferlin is equally 
distributed, only a slight trend towards lesser otoferlin membrane staining from wildtype 
transfected cells over otoferlin RXR transfected cells at 37°C and then incubated at elevated 
temperature could be observed. In addition less otoferlin is present compared to the wild type 






Figure 4.19: Staining of Otof-/- transfected inner hair cells with cDNA of otoferlin RXR at different 
temperatures. A) Incubated at 37°C, left merge of both channels, right otoferlin staining. B) Incubated at 





Figure 4.20: Different graphs showing the results of Imaris analysis, comparing wild type otoferlin 
transfected cells and otoferlin RXR transfected cells at 37°C at 38.5°C. Error bars show SEM. GG=Gene 
Gun, RXR=otoferlin containing RXR motif. n=6 (GG WT), n=4 (RXR 37°C), n=4 (RXR 38.5°C) 
 
After those experiments I cloned another vector containing, in addition to the RXR motif, also 




incubated at 37°C and elevated temperature and after immunofluorescence staining analyzed 
using Imaris software. 
Otof-/- cells transfected with otoferlin I515T RXR show reduced otoferlin membrane staining  
After transfection of Otof-/- cells with otoferlin RXR I515T cDNA via Gene Gun, cells were stained 
after incubation at different temperatures (compare Fig. 4.21),  performed accordingly to cells 
transfected with otoferlin RXR. This revealed that the cells do not show any membrane staining.  
 
Figure 4.21: Staining of Otof-/- transfected inner hair cells with cDNA of otoferlin RXR I515T at different 
temperatures. A) Incubated at 37°C, left merge of both channels, right otoferlin staining. B) Incubated at 




Analyzing these cells using Imaris software confirmed the observation. Having a look at the 
ratio of apical/basal distribution the amount of with otoferlin RXR I515T mutation transfected 
cells is lower. Additionally, when looking at the otoferlin membrane distribution the values for 
transfected cells with mutated otoferlin display negative numbers, showing that no membrane 







Figure 4.22: Different graphs showing the results of Imaris analysis, comparing wild type otoferlin 
transfected cells and otoferlin RXR I515T transfected cells at 37°C at 38.5°C. Error bars show SEM. 
GG=Gene Gun, RXR I515T=otoferlin containing RXR motif and I515T mutation. n=6 (GG WT), n=14 (RXR 
IT 37°C), n=7 (RXR I515T 38.5°C)  
 
For cells incubated at higher temperature we expected an even lower membrane staining 




show any membrane staining. With the method I was using it is apparently not possible to 
quantify that. 
Transfection of Otof-/- cells with otoferlin del C2F cDNA results in reduced otoferlin membrane 
staining 
Apart from the temperature sensitive mutations in otoferlin another one is the so called 
pachanga mutation, which is localized in the C2F domain. Immunofluorescence stainings of mice 
with this mutation showed a greatly reduced amount of otoferlin (Pangrsic et al., 2010), which 
is even lower than the one seen in OtofI515T/I515T. I was interested how otoferlin is distributed in 
the cell if the whole C2F domain is removed and if it is comparable to the distribution observed 
in inner hair cells of pachanga mice.  
After transfection of Otof-/- cells with otoferlin del C2F cDNA cells were incubated for 2 days and 
then immunostained against otoferlin and VGlut3 (compare Fig. 4.23). After analyzing the cells 
using Imaris software (compare Fig. 4.24) it was revealed, as it can also be seen on the pictures, 





Figure 4.23: Two Otof-/- cells transfected with otoferlin del C2F. Left merge of both cannels, right 






Figure 4.24: Different graphs showing the results of Imaris analysis, comparing wild type otoferlin 
transfected cells and otoferlin del C2F transfected cells. Error bars show SEM. GG=Gene Gun, del 







Otoferlin has been subject of many studies after it was discovered in 1999 (Yasunaga et al., 
1999). It was proposed that otoferlin plays a role in the late step of exocytosis (Roux et al., 
2006) as well as in endocytosis-exocytosis coupling via an interaction with the clathrin adapter 
protein 2 (AP2) (Duncker et al., 2013; Jung et al., 2015) and vesicle priming (Pangrsic et al., 
2010). Since otoferlin knock out mice are profoundly deaf it is for sure essential for the hearing 
process. Recently, the hypothesis of otoferlin playing a role in vesicle priming was supported by 
a publication showing a reduced number of short tethers which connect synaptic vesicles with 
the active zone membrane in Otof-/- mice (Vogl et al., 2015).  
One of the aims of this study was to investigate the I515T mutation which occurs in human 
same as in mice, but interestingly only leads to deafness in humans at elevated body 
temperature. A mouse line for this mutation is available and was the subject of intensive 
studies (Strenzke et al., 2016). 
Additionally, I was interested in the characterization of otoferlin constructs missing single C2 
domains. Since another well studied mutation called “pachanga” is localized in the C2F domain 
(Pangrsic et al., 2010), I focused on investigation of otoferlin missing this domain.  
Third, I tried to strengthen the evidence for dynamin and OPA1 as possible otoferlin interaction 
partners using proximity ligation assay and tested the stability of wildtype otoferlin and 






5.1 Determined mRNA levels in organs of Corti from 
OtofI515T/I515T mice show no reduction in comparison to 
mRNA of wild type mice  
 
One speculated mechanism for the I515T phenotype was that there may be reduced otoferlin 
mRNA levels in OtofI515T/I515T inner hair cells. This can either originate from lower expression as 
well as accelerated degradation of mRNA. The latter can occur when the mRNA is for example 
recognized as defective. Additionally, different mRNAs can vary in their half-life times and are 
not present for a very long time. I found no statistic reduction when otoferlin mRNA levels of 
wild type mice and of OtofI515T/I515T mice were compared to each other, neither normalized to 
TBP nor bassoon as an inner hair cell control. Thus, a lower mRNA level seems not to be the 
reason for the lower protein levels in otoferlin mutant mice. Similar experiments were 
conducted in the deaf Otofpga/pga mice (Pangrsic et al., 2010). It was shown that those mice, 
comparable to OtofI515T/I515T mice, also have a trend towards higher mRNA level compared to 
those of wild type mice. We concluded, that reduced amounts of mRNA levels were not the 
reason for both, the I515T as well as the pachanga phenotype. The next possible mechanism we 
had in mind was increased degradation of otoferlin protein carrying a temperature sensitive 
mutation. 
 
5.2 Otoferlin protein as well as the temperature sensitive 
forms are not degraded by a proteasomal mechanism  
 
Small changes in an amino acid sequence, as it is the case with temperature sensitive mutations 
in otoferlin, can already lead to defects regarding folding or stability (Lascu et al., 1997). To test 
this hypothesis, I performed Cycloheximide experiments with transfected HEK cells, blocking 




distinct cDNA of wild type or a mutated form of otoferlin and incubated at 37°C or 38.5°C for 
two hours, a time range in which patients carrying the I515T mutation were already deaf  
(Varga et al., 2006b).  
Our first attempt of analyzing those samples was Western Blot analysis. This method of 
blocking the protein biosynthesis with Cycloheximide, loading the samples on a polyacrylamide 
gel and blot the protein to a membrane was successfully conducted with small proteins such as 
Heat shock 70kDa protein 1A (Jiang et al., 2004) or zinc-finger-containing transcriptional 
repressor (Slug) (Kao et al., 2014). This raised hope for a larger protein like otoferlin (~230kDa) 
as well assuming that we use a proper working antibody. Unfortunately, I came across several 
problems. First the α-otoferlin antibody binding in the C2C domain (Abcam) was not working 
reliably, sometimes showing protein bands of expected size in Western Blots, sometimes 
leading to several, unspecific bands on the blot and sometimes not binding at all. Variation of 
the blotting procedure regarding blotting time, current and detection reagent did not yield in 
consistent data. In addition, the intensity of the putative otoferlin band as well as of the loading 
control band was not only based on the amount of protein itself but seemed to be influenced 
by the position on the membrane, a phenomenon which was observed by loading same sample 
and same amount on one gel and blotting it. All this taken together made me give up on that 
method because it was not reproducible and not reliable. Since we expected minor changes of 
the otoferlin protein levels the technique of comparing the intensity of Western Blot bands is 
maybe not sensitive enough to determine such small differences, but this can only be ruled out 
by overcoming the mentioned problems. However, the approach of half-life-time 
determination using Western Blots was not completely useless because I optimized sample 
preparation and storage which came in handy for the next procedure. I observed that lysed HEK 
cells are better frozen directly and kept at -20°C until further treatment instead of keeping 
them only on ice. Importantly it turned out, that otoferlin seems to aggregate when it is heated 
in Laemmli buffer which is a common procedure for polyacrylamide samples. It was proofed 




Since we needed a method to determine the change in otoferlin protein levels and examine 
protein degradation we switched from Western Blot to mass spectrometry. Several proteins 
were analyzed regarding their half-life-time so far (Sandoval et al., 2013; Chen et al., 2016) 
which motivated us to perform similar experiments for otoferlin as well. It turned out that wild 
type otoferlin as well as the mutated forms in HEK cells are more stable than expected and the 
protein level is not significantly reduced after an incubation time of two hours. Extending the 
incubation time to 24h and analyzing the protein amount in transfected cells with either wild 
type otoferlin or OtofI515T/I515T still showed that even until this extended time span otoferlin 
levels still do not significantly decrease, neither wild type otoferlin but more interestingly nor 
OtofI515T/I515T protein levels.  
My results indicate that fast proteosomal degradation is not the reason for temperature 
sensitive hearing loss. Another possible explanation for the temperature dependent hearing 
phenotype was that mutated otoferlin protein levels could originally be a little lower and drop 
below a certain threshold as soon as the body temperature rises, leading to deafness. At least 
in HEK cells the protein levels of mutated otoferlin were comparable to those of non-mutated 
otoferlin, showing if anything even a small trend towards higher levels. This might be an 
artefact of the organism properties, as by studying the mutant mouse lines OtofI515T/I515T and 
Otofpga/pga it was shown that otoferlin protein levels are in contrast decreased  to those in HEK 
cells (Pangrsic et al., 2010; Strenzke et al., 2016),  
However, it cannot be excluded that the protein unfolds within a short time period at elevated 
temperatures and is no longer functional. The protein might then fold back to its normal 
structure when the body temperature is back at a normal level. This unfortunately cannot be 
investigated using mass spectrometry analysis since even unfolded protein would remain inside 
the cell and would then be processed as normally folded protein. Nevertheless it cannot be 
excluded that mutated otoferlin is degraded faster than wild type otoferlin although the 
degradation is not as fast as expected. However, due to the fact that HEK cells would not 
endure the used Cycloheximide concentration for a time span longer than 24h it is not possible 




Modelling the C2C domain (compare Fig. 5.1) of otoferlin with the I515T mutation (model kindly 
provided by Piotr Neumann) could show a possible explanation for the temperature sensitive 
hearing loss related to the I515T mutation. Here, the I515T points towards the center of the C2C 
domain. Since the hydrophobic inner core strongly contributes to the protein domain stability 
by hydrophobic interaction of the non-polar side chains, the exchange from a hydrophobic 
(isoleucine) to a hydrophilic (threonine) amino acid is likely to render the protein less stable 
which could be an explanation for the I515T phenotype. 
 
Figure 5.1: Model of the C2C domain of otoferlin with I515T mutation. The domain is shown either 
without (left) or with (right) amino acid sidechains. Kind gift of Piotr Neumann, figure taken from 
(Strenzke et al., 2016) 
 
5.3 Otoferlin is unlikely to be sumoylated 
 
Different posttranslational modification forms like ubiquitylation or acetylation exist, which 
have an influence on interaction and localization as well as stability. Another important form of 
covalent modification takes place at specific lysine residues by small ubiquitin-like modifiers 
(SUMO). Sumoylation also plays an essential role in the regulation of different biological 




2007). Interestingly it was predicted that the pachanga mutation D1767G destroys a possible 
sumoylation site (predicted using http://sumosp.biocuckoo.org). Thus, sumoylation of otoferlin 
would be a possible mechanism for the degradation or the regulation of cellular localization. 
Using His6-HA-SUMO1 knock-in mice (kind gift of Marilyn Tirard, see also Tirard et al., 2012) it 
turned out that sumoylated proteins can be found inside and around the nucleus of inner hair 
cells but not in the remaining cell. Since otoferlin is distributed through the cell and is present 
at the membrane as well, a HA-signal should be detectable in the whole cell or at least in the 
region of active zones in case of an otoferlin sumoylation. This is not the case for inner hair 
cells, suggesting that neither otoferlin nor other synaptic inner hair cell proteins are 
sumoylated. In vitro experiments by R. Geiss-Friedländer further revealed no sumoylation of 
the otoferlin C2F domain, supporting my immunohistochemical findings. 
 
5.4 Gene Gun transfection could be successfully established for 
inner hair cells in our lab 
 
Transfection of inner hair cells turned out to be more challenging than expected because of 
their orientation in the organ of Corti. Hair cells are protected by the cuticular plate and the 
tectorial membrane above and the basilar membrane below them. The cuticular plate 
especially made it very difficult to transfect inner hair cells when tried to transfect cells with 
tectorial membrane facing upwards and basilar membrane facing to the surface of the petri 
dish. To overcome the tectorial membrane high transfection pressure (200-250psi) was needed 
which lead to damaged or dead cells. Too high pressure combined with lack of space between 
tissue and Gene Gun nozzle can lead to increased tissue damage, which was already mentioned 
in 2001 by O´Brien and colleagues who successfully transfected HeLa and HEK cells (O’Brien et 
al., 2001). They also stated that transfection with a transfection pressure lower than 100psi was 
not effective which was also the case for us. They reduced the incoming pressure burst by using 




transfect cells. In another publication using the Helios Gene Gun, larvae of Bombyx mori were 
transfected using a focusing nozzle (Thomas et al., 2001). Thomas and colleagues were able to 
shoot dried particles as well as wet ones. With their modifications their shooting was always 
centered. We also tried transfecting inner hair cells using a focusing nozzle and lower pressure 
(20-60psi) since higher pressure destroyed inner hair cells or led to blown-away tissue. 
Unfortunately this did not yield in success for mouse inner hair cells. The most interesting 
modifications of this method were released in a publication in 2012 (Zhao et al., 2012) working 
mainly with bullfrog saccule hair cells but also with hair cells of chicken and mouse. They 
focused on reducing the shockwave on the tissue but maintained penetrating power which was 
also an important component for our transfection. Since the mentioned modification of O´Brian 
and colleagues as well as Thomas and colleagues did not work for them they built a semi-air dry 
chamber mostly out of common lab equipment like the cap of a falcon tube. In addition, to 
reduce the pressure, they were using a mesh with a diameter of 74µm. Based on those 
modifications, my colleague Hanan Al-Moyed and I started using meshes, either one or two in 
different combinations of 40µm and 70µm. It turned out that two meshes with 70µm in 
diameter, glued on top of each other, gave the best transfection results. To maintain the 
distance between nozzle and tissue, a self-build tripod was used (adapted from Michael Leitner 
and Dominik Oliver, Marburg), (for an overview of the setting compare Fig. 4.16). Finally we 
tried to increase the pressure and amount of transfected inner hair cells in the organ of Corti by 
flipping the tissue and having the basilar membrane facing up. Although the amount varied 
between different shooting experiments, it most of the times led to successfully transfected 
inner hair cells. Since it turned out that only with p4 mice transfection led to fluorescent inner 
hair cells it can now be speculated whether the mice were always precisely of that indicated 
age. Maturation happens quickly in the first days, so when a litter was not always discovered on 
the day of birth which can happen since the female mice tend to hide their pups, mice could be 
little older than p4 what makes it nearly impossible to transfect cells but anyway greatly 





5.5 It seems that a small amino acid stretch including a RXR 
motif is the reason for the I515T phenotype 
 
The OtofI515T/I515T mutant is a suitable mouse model which has been studied for a long time and 
produced a high amount of data (Strenzke et al., 2016). However, it appeared strange that 
those mice do not become deaf at elevated body temperature but humans carrying the same 
mutation become rapidly deaf indeed as soon as their body temperature rises. This made us 
wonder if a difference in the amino acid sequence of mouse and human otoferlin could be the 
reason. It turned out that indeed, apart from a few minor differences, a short amino acid 
stretch of twenty amino acids including an RXR motif is missing in the mouse sequence but 
existing in the human as well as in rat and Xenopus (Strenzke et al., 2016).  
Earlier studies investigating the function of α2c-adrenergic receptor (AR) revealed that this 
receptor also has a strange temperature dependent localization pattern (Filipeanu, 2015). The 
α2c-AR plays an important role in a disease called Raynaud’s phenomenon, first described by 
Maurice Raynaud in 1862. Patients having Raynaud´s phenomenon observe a strong response 
when exposed to cold, the following effects appear one after another. First, because of local 
perfusion, the affected skin turns from normal color to white. Second, the affected skin turns 
from white to blue because of hypoxia. At last, after a short time span, the blood flow is 
restored and the skin turns red accompanied by great pain (Brand et al., 1997; Prete et al., 
2014). It turned out that the mentioned receptor includes several putative RXR motifs which in 
other proteins prevents the protein from transport to the cell surface but in contrast supports 
the retention in the endoplasmic reticulum (Michelsen et al., 2005; Stepanchick et al., 2010). 
Comparison of α2C-AR and α2B-AR, the latter is missing these R R motifs, showed that α2B-AR is 
not transported to the membrane at decreased temperatures (Filipeanu et al., 2011). It was 
found that the plasma membrane levels of α2c-AR were increased in HEK cells transfected with 
cDNA of human, mouse or rat when cells were exposed to lower temperature (30°C), since 
Raynaud´s phenomenon occurs at decreased temperatures. The three mentioned species 




transfected with cDNA of α2c-AR from opossum, having less arginine clusters. It turned out that 
the membrane localization of opossum protein at reduced temperature was not statistically 
increased whereas it was for the other three species though.  
Indeed, it seems that also in otoferlin the RXR motif might be one explanation why humans 
having the I515T phenotype become deaf at elevated temperatures whereas mice do not. At 
normal body temperature of 37°C, a remarkable fraction of I515T-otoferlin is localized at the 
plasma membrane of inner hair cells but when the body temperature is increased the fraction 
of protein at the plasma membrane is reduced (observation from Hanan Al-Moyed, Strenzke et 
al., 2016). Since the localization at normal body temperature is different, for the α2c-AR in the 
endoplasmic reticulum and for otoferlin at the plasma membrane, the RXR motif seems to 
trigger relocation towards the plasma membrane at decreased temperature in the case of α2c-
AR and towards intracellular membranes at elevated body temperature in the case of otoferlin. 
Thus, the relocation due to the RXR motif in both cases reduces plasma membrane levels with 
increasing temperature. 
In 2015 Redpath and colleagues conducted a study where they investigated the expression and 
localization of the six mammalian ferlins in three different cell lines including HEK cells (Redpath 
et al., 2015). They claim that in the tested cell lines myoferlin and dysferlin are expressed in the 
plasma membrane and support the endo-lysosomal pathway whereas otoferlin is localized to 
the trans-golgi and recycling networks and is localized at the membrane only in very low 
amounts. This is in stark contrast to what we observed in inner hair cells of wild type mice 
where we see a strong membrane staining. The staining, and with that the amount of otoferlin 
protein, is indeed reduced in the two investigated otoferlin mouse mutants Otofpga/pga and 
OtofI515T/I515T, by 65% in the latter (Pangrsic et al., 2010, Strenzke et al., 2016), but still 
detectable. However, the localization to the trans golgi compartment is in line with supposed 
roles of otoferlin that include recycling of synaptic vesicles (Strenzke et al., 2016) as well as 
synaptic exocytosis (Roux et al., 2006). One explanation for the varying results regarding the 
membrane localization of otoferlin could be that our results were obtained in mouse inner hair 




different cell lines, HEK293, Cos-7 and C2C12 myoblasts, by overexpression of the different 
human proteins. It seems that at least for otoferlin, the localization differs depending on the 
cell type. Regarding the weak membrane localization the authors suggested a closely coupled 
endocytosis and exocytosis. This results in otoferlin being only transiently at the membrane, 
which is also in line with the endocytosis-exocytosis coupling via an interaction with the clathrin 
adapter protein 2 (AP2) (Duncker et al., 2013; Jung et al., 2015). In addition, Redpath and 
colleagues mentioned that overexpression of proteins does not always lead to reliable results 
but was the only possible method for their study since no antibodies binding the 
lumina/extracellular domains of the human ferlins antibodies were available.  
 
5.6 Proximity ligation assay could not be established for use in 
inner hair cells 
 
A few interaction partners of otoferlin have been verified using different approaches like yeast 
two-hybrid, surface plasmon resonance or pull-down assays. However, to date the identified 
interaction were never reviewed if the really interact in inner hair cells. Proximity ligation assay 
seemed to be a useful tool to check the already existing interactions and also identify new ones. 
Since I had two promising interaction partners of otoferlin, identified by pull down assays 
performed by Sandra Meese (Molecular Structural Biology, Ralf Ficner) and Sunit Mandad 
(Bioanalytical Mass Spectrometry Group), dynamin and OPA1, I wanted to strengthen the 
interaction hypothesis using proximity ligation assay. This assay leads to a fluorescent spot if 
the two secondary antibodies, which bind to the primary antibody detecting the proteins, are in 
proximity of  0nm or less. By staining the inner hair cells with α-calbindin antibody, it was easily 
visible if signals were inside or outside the cells and where exactly in the cell they are located. It 
turned out that in four positive controls the fluorescent spots were not restricted to inner hair 
cells. Another publication using proximity ligation assay as one of their methods shows the use 




Smad1/5/8 and Smad4 in Neuro2a cells after treatment with bone morphogenetic protein 4 
(Thymiakou and Episkopou, 2011). As negative controls, cells were incubated with just one 
primary antibody, no positive control was performed. After PLA they observed signals which 
were restricted to the cells, no other signals have been detected. In the negative control no 
fluorescent spots were visible. In another publication no interaction could be proven. It was 
tested weather transferrin receptor 2 (Trf2) and hemochromatosis protein (Hfe) are in close 
proximity which was not the case (Rishi et al., 2013). The study was conducted in Hepa 1-6 cells 
stably expressing Hfe or Trf2. Same as Thymiakou and Episkopou, negative controls with just 
one antibody were used. However, it was shown that Trf1 and Trf2 are leading to a fluorescent 
signal, indicating the formation of heterodimers whereas Hfe did interact with Trf1 but not Trf2. 
Their negative controls are clearly negative and their experiments show clear signals for Hfe 
and Trf1 but not Trf2 as well as Trf1 and Trf2.  
Although in both publications no positive control is included, both researchers went for 
negative controls. Unfortunately, even our negative control, which was conducted in Otof-/-  
mice using α-otoferlin and α-OPA1 antibody ended up in fluorescent spots, most of them 
between cells but a few inside the cells as well. It turned out they looked similar in the positive 
controls, where I observed fluorescent signals inside the cells where they were supposed to be, 
as well as in between inner hair cells, no matter which antibody combination was used as a 
positive control. To my knowledge, so far no scientific publication exists which includes 
successful proximity ligation assay results and show a close proximity of two cochlear inner hair 
cell proteins. Although immunofluorescence staining for many inner hair cell proteins can be 
easily performed, their epitope binding may not be strong enough for proximity ligation assays. 
In addition, in both publications blocking solution and antibody diluent were used which come 
together with the used PLA probes. Because using those for our antibodies did not work in 
inner hair cells at all, I switched to the common immunofluorescence solution used in our 
laboratory. For blocking donkey serum (DSDB) supplemented with Triton-X-100 was used, for 
diluting primary antibodies as well as PLA probes I used DSDB without Triton because Triton 
seemed to hinder the enzymes from their work. Both could be the reason why PLAs did not 




be further optimized. Since it turned out during my studies that otoferlin and dynamin or OPA1 
were not interacting using yeast two-hybrid assay (Sarah Helfmann, Molecular biology of 
cochlear neurotransmission group) and PLAs did not show convincing results, I did not proceed 
with that method. 
 
5.7 The otoferlin C2F domain apparently plays a role for plasma 
membrane localization 
 
Inner hair cells were biolistically transfected with otoferlin del C2F cDNA and stained after two 
days in culture using α-otoferlin and α-VGlut3 antibodies. It turned out that the otoferlin 
plasma membrane staining in those cells is nearly completely vanished. Inner hair cells with 
similar low fraction of plasma localized otoferlin can be observed in Otofpga/pga mice (Pangrsic et 
al., 2010). Those mice seem to have normal inner hair cell mechano-electrical transduction as 
well as normal basolateral Ca2+ conductance and a normal readily releasable pool. Interestingly, 
the change in membrane capacity rose more slowly in those mutants when cells were 
depolarized longer, indicating that the sustained exocytosis is not working properly. Increasing 
the Ca2+-concentration enhanced the sustained exocytosis in those mutants. The pachanga 
mutation is caused by a missense mutation in the C2F domain of otoferlin (D1767G in mus 
musculus otoferlin variant 1, NP_001093865). It was predicted earlier that the last four C2 
domains of otoferlin, meaning C2C to C2F, are critical for Ca2+-binding and thus for protein 
function and hearing (Yasunaga et al., 2000). Later it was stated in another publication, that 
only C2D, C2E and C2F have the five aspartates needed for Ca2+ binding (Jiménez and Bashir, 
2007). This was confirmed by Ca2+ binding experiments performed by Sandra Meese (Molecular 
Structural Biology, Ralf Ficner). For the C2F domain of otoferlin it was shown, that it binds 
Phosphatidylinositol 4,5-bisphosphate (PIP2) in a Ca2+ independent manner (Padmanarayana et 
al., 2014). PIP2 is a phospholipid component of cell membranes. In my biolistically transfected 




that the C2F domain is important for plasma membrane binding, maybe by an interaction with 
PIP2.  
It can be hypothesized, based on my experiments, that the deletion of the C2F domain might 
have an influence on the function. Since I can now only make a statement regarding the 
distribution of otoferlin in inner hair cells, it cannot be said if the hearing phenotype would be 
comparable to pachanga phenotype. However, the pachanga mutation consists of only an 
exchange of one amino acid and already has severe influences on hearing, leading to complete 
deafness of those mice. It is possible, that deleting the whole domain would lead to a similar 
phenotype, also indicated by the comparable protein distribution in immunofluorescence 
stainings.  
In addition, cells transfected with otoferlin RXR I515T cDNA incubated at 38.5°C are also missing 
otoferlin membrane staining and patients carrying this mutation become deaf at elevated body 
temperature. It seems that otoferlin being correctly localized in the plasma membrane is 






Deafness is an interesting and intensely studied topic and can be caused by different, genetic as 
well as environmental, factors. One important cause of deafness are mutations in the otoferlin 
gene leading to non-syndromic deafness DFNB9. Interestingly, some mutations lead to 
temperature induced hearing loss where patients have normal to impaired hearing when their 
body temperature is normal but become deaf as soon as they become febrile. We analyzed 
three temperature sensitive mutations by mass spectrometry to investigate their protein 
stability. It turned out that wildtype otoferlin as well as the mutated forms are stable over a 
time range of 24h although rapid unfolding cannot be excluded.   
Since mice carrying the I515T mutation show lower protein levels, we checked whether these 
levels depend on a lower amount of mRNA. We isolated RNA from organs of Corti from 
wildtype and OtofI515T/I515T mice and conducted Real-Time PCRs. It turned out that in both mice 
mRNA levels were comparable. 
To test the hypotheses if dynamin-1 as well as OPA1 are interaction partners of otoferlin it was 
tried to establish proximity ligation assays. Because it was shown using yeast two-hybrid assays, 
that otoferlin neither interacts with dynamin nor with OPA1 it was no longer focused on that. 
Biolistic transfection of inner hair cells using the Gene Gun could be successfully established in 
our lab. We analyzed, with different modified cDNA, transfected cells regarding their protein 
distribution and membrane bound fraction of otoferlin. It could be shown that otoferlin with a 
missing C2F domain is no longer localized to the membrane indicating an important role for this 
domain.  
Cells biolistically transfected with otoferlin RXR did not lead to a reduction in otoferlin 
membrane staining whereas those with an additional I515T mutation show no membrane 
staining. It could be shown that cochlear mouse otoferlin is missing the RXR motif present in 
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Table A1: Used primers for obtaining C2 domain deletion constructs or constructs with an additional RXR 
domain. For better clarity recurrent primers are highlighted.  
Name of primer Sequence of primer 5’ -> 3’ 
pEGFPN1mOtof del C2A, for CTTCGAATTCGCCACCATGGCCGCCACAGATGGCACTGT
GGGC 
pEGFPN1mOtof del C2A, rev ATCTTGTCTTTGGGGCTCCT 
pEGFPN1mOtof del C2B PCR1, for AAGGACAGCCAGGAGACAGA 
pEGFPN1mOtof del C2B PCR1, rev TGCCCACCACCTGGTAATCCATGGGCCTTC 
pEGFPN1mOtof del C2B PCR2, for ATTACCAGGTGGTGGGCAAGGGAGACAAC 
pEGFPN1mOtof del C2B PCR2, rev GCTGCTCTTCTGCACTGATG 
pEGFPN1mOtof del C2C PCR1, for AAGGACAGCCAGGAGACAGA 
pEGFPN1mOtof del C2C PCR1, rev AGTTGCGCGTCCGTGCCCACTGCCGTTC 
pEGFPN1mOtof del C2C PCR2, for GTGGGCACGGACGCGCAACTACACACTGCTG 
pEGFPN1mOtof del C2C PCR2, rev ACAGAGGCGTGTCAGGATCT 
pEGFPN1mOtof del C2F PCR1, for ATGTTGACAGTGGCCGTGTA  
pEGFPN1mOtof del C2F PCR1, rev CATTCTCATTCTCGTACTTCTTGGGTTTCC 
pEGFPN1mOtof del C2F PCR2, for GAAGTACGAGAATGAGAATGATGAGTTTGAGC 
pEGFPN1mOtof del C2F PCR2, rev GCTGAACTTGTGGCCGTTTACG  
pEGFPN1mOtof RXR PCR1, for CAATGATTGACCGGAAAAATGGGG 
pEGFPN1mOtof RXR PCR1, rev CACAGCACACGGCAGCGCCGGAGAAGCCTGACCGTGG
TGTTCCAGCTGGGGGCTGAGCGGTCTGG 
pEGFPN1mOtof RXR PCR2, for CGGCGCTGCCGTGTGCTGTGCAATGGGGGCTCCTCCTC
TCACTCCACAGGGGAGGTTGTAGTAAGC 







Table A2: Used primers for obtaining point mutation deletion constructs. For better clarity recurrent 
primers are highlighted. 
Name of primer Sequence of primer 5’ -> 3’ 
pEGFPN1mOtof I515T 1, for CGTTCATCGGTGAGAACAAG  
pEGFPN1mOtof I515T 1, rev GCGCAGGTCGGTGAAGTGGGTGCCGATGG 
pEGFPN1mOtof I515T 2, for ACCCACTTCACCGACCTGCGCAAGATTTCC 
pEGFPN1mOtof I515T 2, rev ACAGAGGCGTGTCAGGATC 
pEGFPN1mOtof G541S 1, for CGTTCATCGGTGAGAACAAG  
pEGFPN1mOtof G541S 1, rev GCGTGGAGCTGTACATGTTCACCCAGGCTG 
pEGFPN1mOtof G541S 2, for GAACATGTACAGCTCCACGCGCAACTACAC 
pEGFPN1mOtof G541S 2, rev ACAGAGGCGTGTCAGGATC 
pEGFPN1mOtof R1607W, for CGTTCATCGGTGAGAACAAG  
pEGFPN1mOtof R1607W, rev TCATGGGGTCCCACCAGATATTGTAGCCATGTATG 
 
Table A3: Used primers for identification of differences between mouse and human otoferlin. For better 
clarity recurrent primers are highlighted. 
Name of primer Sequence of primer 5’ -> 3’ 
PCR RXR motif, for TCATCTACCGACCTCCAGACC 
PCR RXR motif, rev CACATCCACCTTGACCACAGC 
PCR amino acid stretch, for AAGGACAGCCAGGAGACAGA 
PCR amino acid stretch, rev ATCTTGTCTTTGGGGCTCCT 
 
Table A4: Used primary antibody for immunofluorescence stainings as well as proximity ligation assays 
Target Source Dilution Name Provider 
Calbindin goat 1:150 Calbindin D28K (C20) Santa Cruz 
CtBP2 mouse 1:200 Purified Mouse Anti-CtBP2  Clone  
16/CtBP2  (RUO) 
BD Bioscience 






rabbit 1:500  rabbit polyclonal, antiserum 
 
Synaptic Systems 
GFP rabbit 1:500 GFP Tag Antibody, Alexa Fluor® 488 
conjugate, Molecular Probes™ 
Thermo Fisher 
Scientific 
Hemagglutinin rabbit 1:300 Anti-HA tag antibody ChIP Grade Abcam 
Myosin 6 rabbit 1:200 Myosin-VI Rabbit Polyclonal Antibody Proteus 
Biosciences 
OPA1 rabbit 1:400 Anti-OPA1 antibody [EPR11057(B)] Abcam 
Otoferlin mouse 1:300 Monoclonal Otoferlin antibody [13A9] Abcam 
Otoferlin rabbit 1:500 Polyclonal rabbit antibody against 
Otoferlin 
Synaptic Systems 
Ribeye rabbit 1:1000 U2656 (see Schmitz et al., 2000)  




Table A5: Used secondary antibody for immunofluorescence stainings 
Target Source Dilution Name Provider 
mouse goat 1:200 goat anti mouse 405 IgG (H+L) Invitrogen 
mouse goat 1:200 goat-anti-mouse 568 IgG H+L Life Technologies 
mouse goat 1:200 goat anti-mouse 594 IgG (H+L)   Invitrogen 
rabbit goat 1:200 goat anti-rabbit 488 Invitrogen 
rabbit goat 1:200 goat-anti-rabbit 568 IgG (H+L) Life Technologies 
goat donkey 1:200 donkey anti-goat 568 Invitrogen 
mouse donkey 1:200 donkey anti mouse 488 Thermo Fisher Scientific 
rabbit donkey 1:200 donkey anti rabbit 488 IgG (H+L) Invitrogen 
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